Frequencies for first 10,000 rows of pt variable in reac2015q2 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- 21-hydroxylase deficiency | 1 0.01 0.01 Abasia | 17 0.17 0.18 Abdominal abscess | 2 0.02 0.20 Abdominal discomfort | 29 0.29 0.49 Abdominal distension | 13 0.13 0.62 Abdominal hernia | 3 0.03 0.65 Abdominal infection | 2 0.02 0.67 Abdominal injury | 1 0.01 0.68 Abdominal pain | 42 0.42 1.10 Abdominal pain lower | 6 0.06 1.16 Abdominal pain upper | 27 0.27 1.43 Abnormal behaviour | 6 0.06 1.49 Abnormal dreams | 1 0.01 1.50 Abnormal faeces | 1 0.01 1.51 Abnormal loss of weight | 1 0.01 1.52 Abnormal weight gain | 2 0.02 1.54 Abortion spontaneous | 5 0.05 1.59 Abortion threatened | 1 0.01 1.60 Abscess | 2 0.02 1.62 Abscess intestinal | 3 0.03 1.65 Abscess limb | 1 0.01 1.66 Acarodermatitis | 2 0.02 1.68 Accelerated hypertension | 1 0.01 1.69 Accessory navicular syndrome | 1 0.01 1.70 Accident | 1 0.01 1.71 Accident at work | 2 0.02 1.73 Accidental exposure to product | 1 0.01 1.74 Accidental overdose | 2 0.02 1.76 Acidosis | 1 0.01 1.77 Acne | 10 0.10 1.87 Acquired epiblepharon | 1 0.01 1.88 Activities of daily living impaired | 8 0.08 1.96 Acute coronary syndrome | 1 0.01 1.97 Acute graft versus host disease | 1 0.01 1.98 Acute hepatic failure | 4 0.04 2.02 Acute hepatitis B | 1 0.01 2.03 Acute kidney injury | 12 0.12 2.15 Acute lung injury | 1 0.01 2.16 Acute myeloid leukaemia | 1 0.01 2.17 Acute myocardial infarction | 8 0.08 2.25 Acute promyelocytic leukaemia | 1 0.01 2.26 Acute psychosis | 1 0.01 2.27 Acute respiratory distress syndrome | 4 0.04 2.31 Acute respiratory failure | 2 0.02 2.33 Adenocarcinoma of colon | 1 0.01 2.34 Adenoidal hypertrophy | 1 0.01 2.35 Adenomyosis | 1 0.01 2.36 Adrenal insufficiency | 1 0.01 2.37 Adrenal mass | 1 0.01 2.38 Adverse drug reaction | 6 0.06 2.44 Adverse event | 25 0.25 2.69 Agitation | 3 0.03 2.72 Agranulocytosis | 3 0.03 2.75 Agraphia | 1 0.01 2.76 Akathisia | 1 0.01 2.77 Alanine aminotransferase increased | 10 0.10 2.87 Alopecia | 19 0.19 3.06 Alpha haemolytic streptococcal infect.. | 1 0.01 3.07 Alpha hydroxybutyrate dehydrogenase i.. | 1 0.01 3.08 Altered state of consciousness | 3 0.03 3.11 Alveolitis | 1 0.01 3.12 Amenorrhoea | 3 0.03 3.15 Amnesia | 15 0.15 3.30 Anaemia | 52 0.52 3.82 Anaemia macrocytic | 1 0.01 3.83 Anaemia postoperative | 7 0.07 3.90 Anaemia vitamin B12 deficiency | 1 0.01 3.91 Anaesthetic complication | 1 0.01 3.92 Anal abscess | 1 0.01 3.93 Anal atresia | 3 0.03 3.96 Anal fissure | 3 0.03 3.99 Anal fistula | 3 0.03 4.02 Anal polyp | 2 0.02 4.04 Anal ulcer | 2 0.02 4.06 Anaphylactic reaction | 5 0.05 4.11 Anaphylactic shock | 3 0.03 4.14 Anastomotic complication | 1 0.01 4.15 Anastomotic leak | 2 0.02 4.17 Anencephaly | 1 0.01 4.18 Aneurysm | 2 0.02 4.20 Anger | 4 0.04 4.24 Angina pectoris | 6 0.06 4.30 Angina unstable | 2 0.02 4.32 Angioedema | 2 0.02 4.34 Angiopathy | 1 0.01 4.35 Anhedonia | 10 0.10 4.45 Animal bite | 1 0.01 4.46 Animal scratch | 1 0.01 4.47 Ankle fracture | 3 0.03 4.50 Ankyloglossia congenital | 1 0.01 4.51 Ankylosing spondylitis | 2 0.02 4.53 Anomalous pulmonary venous connection | 3 0.03 4.56 Anosmia | 1 0.01 4.57 Anti-platelet antibody positive | 1 0.01 4.58 Antinuclear antibody positive | 1 0.01 4.59 Antipsychotic drug level below therap.. | 1 0.01 4.60 Antipsychotic drug level increased | 3 0.03 4.63 Anxiety | 67 0.67 5.30 Anxiety disorder | 1 0.01 5.31 Aorta hypoplasia | 3 0.03 5.34 Aortic aneurysm | 2 0.02 5.36 Aortic arteriosclerosis | 1 0.01 5.37 Aortic disorder | 1 0.01 5.38 Aortic dissection | 1 0.01 5.39 Aortic stenosis | 2 0.02 5.41 Aortic valve atresia | 1 0.01 5.42 Aortic valve incompetence | 3 0.03 5.45 Apathy | 2 0.02 5.47 Apgar score low | 2 0.02 5.49 Aphasia | 9 0.09 5.58 Aphonia | 5 0.05 5.63 Aphthous stomatitis | 2 0.02 5.65 Aplasia | 1 0.01 5.66 Aplastic anaemia | 1 0.01 5.67 Apnoea | 1 0.01 5.68 Apnoea neonatal | 2 0.02 5.70 Apparent death | 1 0.01 5.71 Appetite disorder | 1 0.01 5.72 Application site erythema | 2 0.02 5.74 Application site inflammation | 1 0.01 5.75 Application site pruritus | 1 0.01 5.76 Application site rash | 2 0.02 5.78 Application site vesicles | 1 0.01 5.79 Arnold-Chiari malformation | 3 0.03 5.82 Arrhythmia | 10 0.10 5.92 Arrhythmia supraventricular | 1 0.01 5.93 Arterial disorder | 2 0.02 5.95 Arterial haemorrhage | 1 0.01 5.96 Arterial injury | 1 0.01 5.97 Arterial occlusive disease | 4 0.04 6.01 Arteriosclerosis | 2 0.02 6.03 Arthralgia | 54 0.54 6.57 Arthritis | 33 0.33 6.90 Arthritis infective | 2 0.02 6.92 Arthropathy | 11 0.11 7.03 Arthroscopy | 1 0.01 7.04 Ascites | 4 0.04 7.08 Aspartate aminotransferase increased | 7 0.07 7.15 Asperger's disorder | 2 0.02 7.17 Aspiration | 7 0.07 7.24 Asthenia | 57 0.57 7.81 Asthenopia | 3 0.03 7.84 Asthma | 22 0.22 8.06 Asthmatic crisis | 1 0.01 8.07 Astigmatism | 1 0.01 8.08 Ataxia | 3 0.03 8.11 Atelectasis | 2 0.02 8.13 Atrial fibrillation | 14 0.14 8.27 Atrial flutter | 4 0.04 8.31 Atrial septal defect | 26 0.26 8.57 Atrial tachycardia | 3 0.03 8.60 Atrioventricular block | 2 0.02 8.62 Atrioventricular block complete | 2 0.02 8.64 Atrioventricular block first degree | 1 0.01 8.65 Atrioventricular block second degree | 1 0.01 8.66 Atrioventricular dissociation | 1 0.01 8.67 Atrioventricular septal defect | 2 0.02 8.69 Atrophic vulvovaginitis | 1 0.01 8.70 Attention deficit/hyperactivity disor.. | 3 0.03 8.73 Atypical pneumonia | 1 0.01 8.74 Autism | 3 0.03 8.77 Autoimmune hepatitis | 3 0.03 8.80 Autoimmune thyroiditis | 1 0.01 8.81 Autonomic seizure | 1 0.01 8.82 Axillary mass | 2 0.02 8.84 Axillary pain | 1 0.01 8.85 B-cell lymphoma | 2 0.02 8.87 Back disorder | 5 0.05 8.92 Back injury | 2 0.02 8.94 Back pain | 50 0.50 9.44 Bacterial infection | 2 0.02 9.46 Balance disorder | 16 0.16 9.62 Barrett's oesophagus | 7 0.07 9.69 Basal cell carcinoma | 9 0.09 9.78 Basal ganglia infarction | 2 0.02 9.80 Basedow's disease | 1 0.01 9.81 Basophil count increased | 1 0.01 9.82 Bedridden | 2 0.02 9.84 Benign breast lump removal | 1 0.01 9.85 Benign breast neoplasm | 1 0.01 9.86 Benign intracranial hypertension | 1 0.01 9.87 Benign neoplasm of bladder | 1 0.01 9.88 Benign prostatic hyperplasia | 2 0.02 9.90 Beta haemolytic streptococcal infection | 1 0.01 9.91 Bicuspid aortic valve | 2 0.02 9.93 Bile duct stenosis | 1 0.01 9.94 Biliary anastomosis complication | 1 0.01 9.95 Biliary tract disorder | 1 0.01 9.96 Bipolar I disorder | 2 0.02 9.98 Bipolar disorder | 5 0.05 10.03 Bladder cancer | 3 0.03 10.06 Bladder disorder | 4 0.04 10.10 Bladder dysfunction | 1 0.01 10.11 Bladder granuloma | 1 0.01 10.12 Bladder neoplasm | 2 0.02 10.14 Bladder outlet obstruction | 1 0.01 10.15 Bladder prolapse | 1 0.01 10.16 Blast crisis in myelogenous leukaemia | 1 0.01 10.17 Blepharal pigmentation | 1 0.01 10.18 Blepharitis | 2 0.02 10.20 Blepharospasm | 2 0.02 10.22 Blindness | 12 0.12 10.34 Blindness unilateral | 3 0.03 10.37 Blister | 2 0.02 10.39 Blood alkaline phosphatase increased | 4 0.04 10.43 Blood bilirubin increased | 3 0.03 10.46 Blood calcium decreased | 2 0.02 10.48 Blood calcium increased | 2 0.02 10.50 Blood cholesterol | 1 0.01 10.51 Blood cholesterol increased | 28 0.28 10.79 Blood creatine phosphokinase MB incre.. | 1 0.01 10.80 Blood creatine phosphokinase increased | 2 0.02 10.82 Blood creatinine decreased | 1 0.01 10.83 Blood creatinine increased | 10 0.10 10.93 Blood disorder | 2 0.02 10.95 Blood fibrinogen increased | 2 0.02 10.97 Blood glucose abnormal | 3 0.03 11.00 Blood glucose decreased | 2 0.02 11.02 Blood glucose increased | 19 0.19 11.21 Blood heavy metal increased | 1 0.01 11.22 Blood immunoglobulin E decreased | 1 0.01 11.23 Blood immunoglobulin E increased | 1 0.01 11.24 Blood iron abnormal | 1 0.01 11.25 Blood lactate dehydrogenase increased | 6 0.06 11.31 Blood magnesium decreased | 3 0.03 11.34 Blood parathyroid hormone decreased | 1 0.01 11.35 Blood potassium abnormal | 1 0.01 11.36 Blood potassium decreased | 6 0.06 11.42 Blood pressure abnormal | 2 0.02 11.44 Blood pressure decreased | 11 0.11 11.55 Blood pressure diastolic decreased | 1 0.01 11.56 Blood pressure diastolic increased | 1 0.01 11.57 Blood pressure fluctuation | 5 0.05 11.62 Blood pressure inadequately controlled | 4 0.04 11.66 Blood pressure increased | 30 0.30 11.96 Blood pressure systolic increased | 5 0.05 12.01 Blood sodium abnormal | 1 0.01 12.02 Blood sodium decreased | 1 0.01 12.03 Blood test abnormal | 4 0.04 12.07 Blood testosterone decreased | 2 0.02 12.09 Blood testosterone increased | 1 0.01 12.10 Blood thyroid stimulating hormone inc.. | 1 0.01 12.11 Blood triglycerides increased | 10 0.10 12.21 Blood urea increased | 4 0.04 12.25 Blood uric acid increased | 2 0.02 12.27 Blood urine present | 1 0.01 12.28 Bloody discharge | 1 0.01 12.29 Body height below normal | 1 0.01 12.30 Body height decreased | 14 0.14 12.44 Body temperature abnormal | 1 0.01 12.45 Body temperature decreased | 5 0.05 12.50 Body temperature increased | 1 0.01 12.51 Bone deformity | 1 0.01 12.52 Bone disorder | 8 0.08 12.60 Bone graft | 3 0.03 12.63 Bone lesion | 1 0.01 12.64 Bone loss | 3 0.03 12.67 Bone marrow disorder | 1 0.01 12.68 Bone marrow failure | 5 0.05 12.73 Bone marrow myelogram abnormal | 1 0.01 12.74 Bone metabolism disorder | 1 0.01 12.75 Bone pain | 9 0.09 12.84 Bowel movement irregularity | 1 0.01 12.85 Bradycardia | 6 0.06 12.91 Brain cancer metastatic | 1 0.01 12.92 Brain death | 1 0.01 12.93 Brain herniation | 1 0.01 12.94 Brain hypoxia | 1 0.01 12.95 Brain injury | 6 0.06 13.01 Brain malformation | 2 0.02 13.03 Brain neoplasm | 3 0.03 13.06 Brain neoplasm benign | 2 0.02 13.08 Brain neoplasm malignant | 2 0.02 13.10 Brain oedema | 6 0.06 13.16 Brain scan abnormal | 1 0.01 13.17 Breakthrough pain | 2 0.02 13.19 Breast cancer | 15 0.15 13.34 Breast cancer in situ | 1 0.01 13.35 Breast cancer recurrent | 1 0.01 13.36 Breast cancer stage II | 1 0.01 13.37 Breast mass | 2 0.02 13.39 Breast pain | 1 0.01 13.40 Breath sounds abnormal | 1 0.01 13.41 Breech presentation | 2 0.02 13.43 Bronchiolitis | 1 0.01 13.44 Bronchitis | 14 0.14 13.58 Bronchitis bacterial | 1 0.01 13.59 Bronchitis chronic | 1 0.01 13.60 Bronchomalacia | 1 0.01 13.61 Bronchopneumonia | 2 0.02 13.63 Bronchopulmonary aspergillosis | 3 0.03 13.66 Bronchospasm | 2 0.02 13.68 Brown tumour | 1 0.01 13.69 Bruxism | 2 0.02 13.71 Bundle branch block right | 1 0.01 13.72 Burn oesophageal | 1 0.01 13.73 Burn oral cavity | 1 0.01 13.74 Burning mouth syndrome | 1 0.01 13.75 Burning sensation | 3 0.03 13.78 Bursitis | 7 0.07 13.85 C-reactive protein increased | 5 0.05 13.90 Cachexia | 1 0.01 13.91 Calcinosis | 1 0.01 13.92 Calcium ionised increased | 1 0.01 13.93 Campylobacter gastroenteritis | 1 0.01 13.94 Candida infection | 2 0.02 13.96 Carcinoid crisis | 1 0.01 13.97 Carcinoid syndrome | 1 0.01 13.98 Carcinoid tumour | 3 0.03 14.01 Cardiac aneurysm | 1 0.01 14.02 Cardiac arrest | 7 0.07 14.09 Cardiac death | 2 0.02 14.11 Cardiac discomfort | 1 0.01 14.12 Cardiac disorder | 13 0.13 14.25 Cardiac failure | 11 0.11 14.36 Cardiac failure congestive | 15 0.15 14.51 Cardiac murmur | 7 0.07 14.58 Cardiac procedure complication | 1 0.01 14.59 Cardiac valve disease | 1 0.01 14.60 Cardiac ventricular thrombosis | 1 0.01 14.61 Cardio-respiratory arrest | 7 0.07 14.68 Cardiogenic shock | 3 0.03 14.71 Cardiomegaly | 4 0.04 14.75 Cardiomyopathy | 1 0.01 14.76 Cardiopulmonary failure | 1 0.01 14.77 Cardiotoxicity | 1 0.01 14.78 Cardiovascular disorder | 3 0.03 14.81 Carotid artery stenosis | 2 0.02 14.83 Carotid pulse abnormal | 1 0.01 14.84 Carpal tunnel syndrome | 6 0.06 14.90 Cartilage injury | 1 0.01 14.91 Castleman's disease | 1 0.01 14.92 Cataract | 13 0.13 15.05 Cataract congenital | 1 0.01 15.06 Catatonia | 2 0.02 15.08 Cautery to nose | 1 0.01 15.09 Cellulitis | 7 0.07 15.16 Cellulitis staphylococcal | 1 0.01 15.17 Central core disease | 1 0.01 15.18 Central nervous system lesion | 5 0.05 15.23 Central venous pressure increased | 1 0.01 15.24 Cephalo-pelvic disproportion | 1 0.01 15.25 Cerebellar haemorrhage | 1 0.01 15.26 Cerebellar tumour | 1 0.01 15.27 Cerebral artery thrombosis | 2 0.02 15.29 Cerebral haematoma | 2 0.02 15.31 Cerebral haemorrhage | 10 0.10 15.41 Cerebral infarction | 4 0.04 15.45 Cerebral ischaemia | 1 0.01 15.46 Cerebral palsy | 3 0.03 15.49 Cerebral thrombosis | 1 0.01 15.50 Cerebral ventricle dilatation | 1 0.01 15.51 Cerebrospinal fluid leakage | 1 0.01 15.52 Cerebrovascular accident | 39 0.39 15.91 Cerumen impaction | 1 0.01 15.92 Cervical dysplasia | 1 0.01 15.93 Cervical spinal stenosis | 1 0.01 15.94 Cervical vertebral fracture | 1 0.01 15.95 Chapped lips | 1 0.01 15.96 Cheilitis | 2 0.02 15.98 Chemical injury | 1 0.01 15.99 Chemotherapy | 1 0.01 16.00 Chest X-ray abnormal | 2 0.02 16.02 Chest discomfort | 17 0.17 16.19 Chest pain | 41 0.41 16.60 Chills | 12 0.12 16.72 Choking | 4 0.04 16.76 Choking sensation | 1 0.01 16.77 Cholangiocarcinoma | 1 0.01 16.78 Cholangitis | 1 0.01 16.79 Cholecystectomy | 2 0.02 16.81 Cholecystitis | 3 0.03 16.84 Cholecystitis acute | 1 0.01 16.85 Cholecystitis infective | 1 0.01 16.86 Cholelithiasis | 8 0.08 16.94 Cholesteatoma | 1 0.01 16.95 Cholinergic syndrome | 1 0.01 16.96 Chondrocalcinosis | 1 0.01 16.97 Chondrocalcinosis pyrophosphate | 1 0.01 16.98 Chondrolysis | 1 0.01 16.99 Chondropathy | 1 0.01 17.00 Choroidal detachment | 1 0.01 17.01 Chromaturia | 3 0.03 17.04 Chromosomal deletion | 1 0.01 17.05 Chronic fatigue syndrome | 2 0.02 17.07 Chronic gastritis | 2 0.02 17.09 Chronic gastrointestinal bleeding | 1 0.01 17.10 Chronic hepatitis B | 1 0.01 17.11 Chronic kidney disease | 5 0.05 17.16 Chronic lymphocytic leukaemia | 2 0.02 17.18 Chronic myeloid leukaemia | 4 0.04 17.22 Chronic obstructive pulmonary disease | 15 0.15 17.37 Circulatory collapse | 1 0.01 17.38 Circumstance or information capable o.. | 3 0.03 17.41 Claustrophobia | 1 0.01 17.42 Clavicle fracture | 3 0.03 17.45 Clear cell renal cell carcinoma | 1 0.01 17.46 Cleft lip | 4 0.04 17.50 Cleft lip and palate | 3 0.03 17.53 Cleft palate | 7 0.07 17.60 Closed fracture manipulation | 1 0.01 17.61 Clostridium difficile colitis | 2 0.02 17.63 Clostridium difficile infection | 4 0.04 17.67 Coagulopathy | 3 0.03 17.70 Coarctation of the aorta | 7 0.07 17.77 Coeliac disease | 1 0.01 17.78 Cognitive disorder | 17 0.17 17.95 Cold sweat | 3 0.03 17.98 Colectomy | 1 0.01 17.99 Colitis | 7 0.07 18.06 Colitis microscopic | 1 0.01 18.07 Colitis ulcerative | 35 0.35 18.42 Colon adenoma | 1 0.01 18.43 Colon cancer | 4 0.04 18.47 Colonic abscess | 1 0.01 18.48 Colostomy closure | 1 0.01 18.49 Coma | 5 0.05 18.54 Communication disorder | 1 0.01 18.55 Completed suicide | 1 0.01 18.56 Complication of pregnancy | 1 0.01 18.57 Complications of transplanted kidney | 2 0.02 18.59 Complications of transplanted lung | 1 0.01 18.60 Compression fracture | 1 0.01 18.61 Concomitant disease aggravated | 1 0.01 18.62 Concomitant disease progression | 6 0.06 18.68 Concussion | 1 0.01 18.69 Condition aggravated | 19 0.19 18.88 Confusional state | 17 0.17 19.05 Congenital anomaly | 4 0.04 19.09 Congenital aortic anomaly | 1 0.01 19.10 Congenital aortic dilatation | 1 0.01 19.11 Congenital aortic stenosis | 1 0.01 19.12 Congenital aortic valve stenosis | 2 0.02 19.14 Congenital cardiovascular anomaly | 2 0.02 19.16 Congenital central nervous system ano.. | 1 0.01 19.17 Congenital eye disorder | 1 0.01 19.18 Congenital flat feet | 1 0.01 19.19 Congenital genital malformation | 2 0.02 19.21 Congenital hydronephrosis | 1 0.01 19.22 Congenital inguinal hernia | 1 0.01 19.23 Congenital pulmonary artery anomaly | 2 0.02 19.25 Congenital pulmonary valve atresia | 1 0.01 19.26 Congenital pulmonary valve disorder | 2 0.02 19.28 Congenital teratoma | 1 0.01 19.29 Congenital tricuspid valve atresia | 1 0.01 19.30 Congenital tricuspid valve stenosis | 1 0.01 19.31 Congestive cardiomyopathy | 1 0.01 19.32 Conjunctival haemorrhage | 1 0.01 19.33 Conjunctivitis | 1 0.01 19.34 Conjunctivitis bacterial | 1 0.01 19.35 Constipation | 33 0.33 19.68 Continuous haemodiafiltration | 1 0.01 19.69 Contusion | 13 0.13 19.82 Coordination abnormal | 1 0.01 19.83 Cor triatriatum | 1 0.01 19.84 Coronary artery disease | 9 0.09 19.93 Coronary artery occlusion | 2 0.02 19.95 Coronary artery stenosis | 1 0.01 19.96 Cough | 41 0.41 20.37 Cranial nerve disorder | 1 0.01 20.38 Craniocerebral injury | 1 0.01 20.39 Craniosynostosis | 4 0.04 20.43 Creatorrhoea | 1 0.01 20.44 Crohn's disease | 19 0.19 20.63 Crying | 6 0.06 20.69 Cryptorchism | 2 0.02 20.71 Cushingoid | 2 0.02 20.73 Cyanosis | 5 0.05 20.78 Cyst | 3 0.03 20.81 Cyst removal | 1 0.01 20.82 Cystic lymphangioma | 2 0.02 20.84 Cystitis | 8 0.08 20.92 Cystocele | 2 0.02 20.94 Cytogenetic abnormality | 1 0.01 20.95 Cytomegalovirus chorioretinitis | 1 0.01 20.96 Cytomegalovirus infection | 3 0.03 20.99 Deafness | 3 0.03 21.02 Deafness bilateral | 1 0.01 21.03 Deafness unilateral | 2 0.02 21.05 Death | 275 2.75 23.80 Debridement | 1 0.01 23.81 Decreased activity | 3 0.03 23.84 Decreased appetite | 29 0.29 24.13 Decreased immune responsiveness | 1 0.01 24.14 Decreased interest | 1 0.01 24.15 Decubitus ulcer | 3 0.03 24.18 Deep vein thrombosis | 16 0.16 24.34 Deformity | 3 0.03 24.37 Dehydration | 14 0.14 24.51 Delirium | 3 0.03 24.54 Delusion | 1 0.01 24.55 Dementia | 4 0.04 24.59 Dementia Alzheimer's type | 1 0.01 24.60 Dengue fever | 1 0.01 24.61 Dental care | 2 0.02 24.63 Dental caries | 4 0.04 24.67 Dental implantation | 2 0.02 24.69 Dependence | 1 0.01 24.70 Depressed level of consciousness | 5 0.05 24.75 Depressed mood | 6 0.06 24.81 Depression | 101 1.01 25.82 Dermal cyst | 1 0.01 25.83 Dermatitis | 2 0.02 25.85 Dermatitis acneiform | 2 0.02 25.87 Dermatitis allergic | 1 0.01 25.88 Dermatitis bullous | 1 0.01 25.89 Dermatitis contact | 2 0.02 25.91 Dermatitis diaper | 1 0.01 25.92 Dermatomyositis | 1 0.01 25.93 Developmental delay | 5 0.05 25.98 Device breakage | 2 0.02 26.00 Device dislocation | 9 0.09 26.09 Device expulsion | 1 0.01 26.10 Device failure | 4 0.04 26.14 Device issue | 7 0.07 26.21 Device leakage | 1 0.01 26.22 Device occlusion | 2 0.02 26.24 Device related infection | 4 0.04 26.28 Dextrocardia | 1 0.01 26.29 Diabetes mellitus | 30 0.30 26.59 Diabetes mellitus inadequate control | 1 0.01 26.60 Diabetic coma | 1 0.01 26.61 Diabetic complication | 1 0.01 26.62 Diabetic foot | 1 0.01 26.63 Diabetic ketoacidotic hyperglycaemic .. | 1 0.01 26.64 Diabetic nephropathy | 1 0.01 26.65 Diabetic retinopathy | 1 0.01 26.66 Diabetic vascular disorder | 1 0.01 26.67 Dialysis | 1 0.01 26.68 Diarrhoea | 58 0.58 27.26 Diarrhoea infectious | 1 0.01 27.27 Differential white blood cell count a.. | 1 0.01 27.28 Diffuse large B-cell lymphoma | 1 0.01 27.29 Dilatation ventricular | 1 0.01 27.30 Diplopia | 4 0.04 27.34 Disability | 1 0.01 27.35 Discomfort | 10 0.10 27.45 Disease complication | 1 0.01 27.46 Disease progression | 66 0.66 28.12 Disease recurrence | 1 0.01 28.13 Disorientation | 6 0.06 28.19 Disseminated intravascular coagulation | 6 0.06 28.25 Disseminated tuberculosis | 1 0.01 28.26 Dissociation | 2 0.02 28.28 Disturbance in attention | 10 0.10 28.38 Disuse syndrome | 1 0.01 28.39 Diverticular perforation | 1 0.01 28.40 Diverticulitis | 11 0.11 28.51 Diverticulitis intestinal haemorrhagic | 1 0.01 28.52 Diverticulum | 5 0.05 28.57 Dizziness | 49 0.49 29.06 Dizziness postural | 1 0.01 29.07 Double outlet right ventricle | 1 0.01 29.08 Drooling | 2 0.02 29.10 Drug abuse | 2 0.02 29.12 Drug administered at inappropriate site | 7 0.07 29.19 Drug administration error | 3 0.03 29.22 Drug delivery device implantation | 1 0.01 29.23 Drug dependence | 4 0.04 29.27 Drug dispensing error | 5 0.05 29.32 Drug dose omission | 97 0.97 30.29 Drug effect decreased | 4 0.04 30.33 Drug effect delayed | 1 0.01 30.34 Drug effect incomplete | 8 0.08 30.42 Drug effect increased | 1 0.01 30.43 Drug eruption | 1 0.01 30.44 Drug hypersensitivity | 13 0.13 30.57 Drug ineffective | 106 1.06 31.63 Drug ineffective for unapproved indic.. | 2 0.02 31.65 Drug interaction | 17 0.17 31.82 Drug intolerance | 7 0.07 31.89 Drug level decreased | 1 0.01 31.90 Drug level increased | 3 0.03 31.93 Drug prescribing error | 5 0.05 31.98 Drug reaction with eosinophilia and s.. | 2 0.02 32.00 Drug specific antibody present | 4 0.04 32.04 Drug tolerance | 1 0.01 32.05 Drug tolerance increased | 1 0.01 32.06 Drug withdrawal syndrome | 7 0.07 32.13 Drug-induced liver injury | 5 0.05 32.18 Dry eye | 7 0.07 32.25 Dry mouth | 11 0.11 32.36 Dry skin | 9 0.09 32.45 Dry throat | 2 0.02 32.47 Duodenal ulcer | 1 0.01 32.48 Duodenitis | 1 0.01 32.49 Dysarthria | 7 0.07 32.56 Dysgeusia | 6 0.06 32.62 Dysgraphia | 3 0.03 32.65 Dyskinesia | 5 0.05 32.70 Dyslipidaemia | 2 0.02 32.72 Dysmenorrhoea | 2 0.02 32.74 Dyspepsia | 44 0.44 33.18 Dysphagia | 19 0.19 33.37 Dysphemia | 1 0.01 33.38 Dysphonia | 15 0.15 33.53 Dysphoria | 1 0.01 33.54 Dyspnoea | 69 0.69 34.23 Dyspnoea exertional | 4 0.04 34.27 Dysstasia | 13 0.13 34.40 Dysuria | 3 0.03 34.43 Ear discomfort | 3 0.03 34.46 Ear disorder | 2 0.02 34.48 Ear haemorrhage | 2 0.02 34.50 Ear infection | 3 0.03 34.53 Ear infection viral | 1 0.01 34.54 Ear malformation | 1 0.01 34.55 Ear pain | 3 0.03 34.58 Ear swelling | 1 0.01 34.59 Eating disorder | 2 0.02 34.61 Eating disorder symptom | 1 0.01 34.62 Ebstein's anomaly | 1 0.01 34.63 Ecchymosis | 2 0.02 34.65 Economic problem | 2 0.02 34.67 Ectopic kidney | 1 0.01 34.68 Ectopic pregnancy | 1 0.01 34.69 Ectopic pregnancy with contraceptive .. | 3 0.03 34.72 Eczema | 2 0.02 34.74 Ejaculation disorder | 4 0.04 34.78 Ejaculation failure | 5 0.05 34.83 Ejection fraction | 1 0.01 34.84 Ejection fraction abnormal | 1 0.01 34.85 Electrocardiogram QRS complex prolonged | 1 0.01 34.86 Electrocardiogram QT prolonged | 6 0.06 34.92 Electrocardiogram abnormal | 2 0.02 34.94 Electroencephalogram abnormal | 2 0.02 34.96 Electrolyte imbalance | 3 0.03 34.99 Embedded device | 1 0.01 35.00 Embolic stroke | 3 0.03 35.03 Embolism | 3 0.03 35.06 Embolism venous | 1 0.01 35.07 Emergency care examination | 1 0.01 35.08 Emotional disorder | 6 0.06 35.14 Emotional distress | 31 0.31 35.45 Emphysema | 2 0.02 35.47 Encephalitis | 1 0.01 35.48 Encephalopathy | 1 0.01 35.49 Endocarditis | 2 0.02 35.51 Endodontic procedure | 2 0.02 35.53 Endometrial adenocarcinoma | 1 0.01 35.54 Endometrial hypertrophy | 1 0.01 35.55 Endometriosis | 1 0.01 35.56 Endotracheal intubation complication | 1 0.01 35.57 Enteritis infectious | 3 0.03 35.60 Enterococcal infection | 1 0.01 35.61 Enterocutaneous fistula | 1 0.01 35.62 Eosinopenia | 1 0.01 35.63 Eosinophil count increased | 1 0.01 35.64 Eosinophil percentage increased | 1 0.01 35.65 Eosinophilia | 3 0.03 35.68 Eosinophilic pneumonia | 1 0.01 35.69 Epicondylitis | 2 0.02 35.71 Epidermal necrosis | 1 0.01 35.72 Epididymitis | 1 0.01 35.73 Epilepsy | 4 0.04 35.77 Epistaxis | 13 0.13 35.90 Erectile dysfunction | 7 0.07 35.97 Erosive duodenitis | 1 0.01 35.98 Erosive oesophagitis | 2 0.02 36.00 Eructation | 4 0.04 36.04 Erysipelas | 3 0.03 36.07 Erythema | 21 0.21 36.28 Erythema multiforme | 3 0.03 36.31 Erythema of eyelid | 2 0.02 36.33 Escherichia infection | 2 0.02 36.35 Escherichia sepsis | 1 0.01 36.36 Escherichia urinary tract infection | 1 0.01 36.37 Essential thrombocythaemia | 1 0.01 36.38 Excoriation | 1 0.01 36.39 Exercise tolerance decreased | 3 0.03 36.42 Exomphalos | 1 0.01 36.43 Exophthalmos | 1 0.01 36.44 Exostosis | 4 0.04 36.48 Expired product administered | 5 0.05 36.53 Exposure during breast feeding | 6 0.06 36.59 Exposure during pregnancy | 6 0.06 36.65 Exposure via father | 1 0.01 36.66 Extra dose administered | 1 0.01 36.67 Extrasystoles | 2 0.02 36.69 Extravascular haemolysis | 1 0.01 36.70 Eye allergy | 1 0.01 36.71 Eye disorder | 6 0.06 36.77 Eye haemorrhage | 1 0.01 36.78 Eye infection | 2 0.02 36.80 Eye irritation | 3 0.03 36.83 Eye movement disorder | 4 0.04 36.87 Eye operation complication | 2 0.02 36.89 Eye pain | 8 0.08 36.97 Eye pruritus | 2 0.02 36.99 Eye swelling | 1 0.01 37.00 Eyelid dermatochalasis | 1 0.01 37.01 Eyelid oedema | 3 0.03 37.04 Eyelid ptosis | 1 0.01 37.05 Face oedema | 8 0.08 37.13 Facial bones fracture | 1 0.01 37.14 Facial nerve disorder | 2 0.02 37.16 Facial pain | 1 0.01 37.17 Facial paresis | 3 0.03 37.20 Facial wasting | 1 0.01 37.21 Factor VIII inhibition | 1 0.01 37.22 Faecal incontinence | 1 0.01 37.23 Faecaloma | 1 0.01 37.24 Faeces discoloured | 1 0.01 37.25 Faeces soft | 1 0.01 37.26 Fall | 64 0.64 37.90 Fallot's tetralogy | 9 0.09 37.99 Fascial rupture | 1 0.01 38.00 Fasciitis | 1 0.01 38.01 Fatigue | 110 1.10 39.11 Fear | 12 0.12 39.23 Fear of death | 3 0.03 39.26 Fear of disease | 4 0.04 39.30 Fear of eating | 1 0.01 39.31 Fear of injection | 1 0.01 39.32 Febrile bone marrow aplasia | 1 0.01 39.33 Febrile infection | 1 0.01 39.34 Febrile neutropenia | 14 0.14 39.48 Feeding disorder | 16 0.16 39.64 Feeding disorder neonatal | 2 0.02 39.66 Feeling abnormal | 38 0.38 40.04 Feeling cold | 6 0.06 40.10 Feeling guilty | 1 0.01 40.11 Feeling hot | 4 0.04 40.15 Feeling jittery | 1 0.01 40.16 Feeling of body temperature change | 3 0.03 40.19 Female genital tract fistula | 1 0.01 40.20 Femoral anteversion | 1 0.01 40.21 Femoral artery occlusion | 2 0.02 40.23 Femoral neck fracture | 2 0.02 40.25 Femur fracture | 26 0.26 40.51 Fibrin D dimer increased | 1 0.01 40.52 Fibrocystic breast disease | 1 0.01 40.53 Fibromyalgia | 10 0.10 40.63 Fibula fracture | 1 0.01 40.64 Finger deformity | 4 0.04 40.68 Fistula | 3 0.03 40.71 Flank pain | 3 0.03 40.74 Flatulence | 9 0.09 40.83 Fluid intake reduced | 3 0.03 40.86 Fluid overload | 1 0.01 40.87 Fluid retention | 3 0.03 40.90 Flushing | 15 0.15 41.05 Foetal death | 1 0.01 41.06 Foetal distress syndrome | 2 0.02 41.08 Foetal exposure during pregnancy | 99 0.99 42.07 Foetal growth restriction | 4 0.04 42.11 Foetal heart rate deceleration abnorm.. | 2 0.02 42.13 Foetal hypokinesia | 1 0.01 42.14 Folliculitis | 1 0.01 42.15 Food craving | 1 0.01 42.16 Food intolerance | 1 0.01 42.17 Food poisoning | 1 0.01 42.18 Foot deformity | 7 0.07 42.25 Foot fracture | 9 0.09 42.34 Formication | 2 0.02 42.36 Fracture | 4 0.04 42.40 Fracture nonunion | 2 0.02 42.42 Fractured coccyx | 1 0.01 42.43 Fractured sacrum | 2 0.02 42.45 Frequent bowel movements | 1 0.01 42.46 Frontotemporal dementia | 1 0.01 42.47 Frustration | 1 0.01 42.48 Full blood count abnormal | 1 0.01 42.49 Full blood count decreased | 1 0.01 42.50 Functional gastrointestinal disorder | 1 0.01 42.51 Fungal infection | 6 0.06 42.57 Fungal oesophagitis | 1 0.01 42.58 Furuncle | 2 0.02 42.60 Gait disturbance | 42 0.42 43.02 Galactorrhoea | 1 0.01 43.03 Gallbladder cancer metastatic | 1 0.01 43.04 Gallbladder disorder | 5 0.05 43.09 Gambling | 1 0.01 43.10 Gamma-glutamyltransferase abnormal | 1 0.01 43.11 Gamma-glutamyltransferase increased | 7 0.07 43.18 Gangrene | 2 0.02 43.20 Gastric cancer | 2 0.02 43.22 Gastric cyst | 1 0.01 43.23 Gastric disorder | 12 0.12 43.35 Gastric haemorrhage | 2 0.02 43.37 Gastric infection | 1 0.01 43.38 Gastric perforation | 1 0.01 43.39 Gastric ulcer | 4 0.04 43.43 Gastric ulcer haemorrhage | 4 0.04 43.47 Gastric ulcer helicobacter | 1 0.01 43.48 Gastritis | 7 0.07 43.55 Gastritis erosive | 2 0.02 43.57 Gastroenteritis | 1 0.01 43.58 Gastroenteritis bacterial | 1 0.01 43.59 Gastroenteritis viral | 8 0.08 43.67 Gastrointestinal anastomotic leak | 1 0.01 43.68 Gastrointestinal arteriovenous malfor.. | 1 0.01 43.69 Gastrointestinal carcinoma | 1 0.01 43.70 Gastrointestinal disorder | 7 0.07 43.77 Gastrointestinal haemorrhage | 9 0.09 43.86 Gastrointestinal hypomotility | 1 0.01 43.87 Gastrointestinal infection | 1 0.01 43.88 Gastrointestinal injury | 8 0.08 43.96 Gastrointestinal neoplasm | 1 0.01 43.97 Gastrointestinal pain | 1 0.01 43.98 Gastrointestinal stromal tumour | 1 0.01 43.99 Gastrointestinal ulcer | 3 0.03 44.02 Gastrointestinal ulcer haemorrhage | 1 0.01 44.03 Gastrooesophageal cancer | 1 0.01 44.04 Gastrooesophageal reflux disease | 69 0.69 44.73 Gastrostomy | 1 0.01 44.74 Gene mutation | 1 0.01 44.75 General physical condition abnormal | 3 0.03 44.78 General physical health deterioration | 15 0.15 44.93 General symptom | 4 0.04 44.97 Generalised anxiety disorder | 1 0.01 44.98 Generalised erythema | 1 0.01 44.99 Generalised oedema | 2 0.02 45.01 Generalised tonic-clonic seizure | 9 0.09 45.10 Genital haemorrhage | 4 0.04 45.14 Genital herpes | 1 0.01 45.15 Genital ulceration | 2 0.02 45.17 Gestational diabetes | 1 0.01 45.18 Gingival bleeding | 1 0.01 45.19 Glaucoma | 4 0.04 45.23 Glomerular filtration rate decreased | 1 0.01 45.24 Glossodynia | 3 0.03 45.27 Glucose tolerance impaired | 2 0.02 45.29 Glycosylated haemoglobin increased | 3 0.03 45.32 Goitre | 1 0.01 45.33 Gout | 3 0.03 45.36 Groin pain | 4 0.04 45.40 Gynaecomastia | 4 0.04 45.44 H1N1 influenza | 2 0.02 45.46 Haemangioma | 1 0.01 45.47 Haematemesis | 7 0.07 45.54 Haematochezia | 3 0.03 45.57 Haematocrit decreased | 5 0.05 45.62 Haematoma | 5 0.05 45.67 Haematuria | 1 0.01 45.68 Haemoglobin decreased | 17 0.17 45.85 Haemolysis | 2 0.02 45.87 Haemolytic anaemia | 2 0.02 45.89 Haemoptysis | 9 0.09 45.98 Haemorrhage | 16 0.16 46.14 Haemorrhage in pregnancy | 1 0.01 46.15 Haemorrhage intracranial | 2 0.02 46.17 Haemorrhagic anaemia | 1 0.01 46.18 Haemorrhagic cyst | 1 0.01 46.19 Haemorrhagic diathesis | 1 0.01 46.20 Haemorrhagic stroke | 2 0.02 46.22 Haemorrhoids | 4 0.04 46.26 Haemothorax | 1 0.01 46.27 Hair texture abnormal | 2 0.02 46.29 Hallucination | 3 0.03 46.32 Hallucination, auditory | 3 0.03 46.35 Hallucination, visual | 2 0.02 46.37 Hand deformity | 4 0.04 46.41 Hand fracture | 1 0.01 46.42 Hangover | 1 0.01 46.43 Head discomfort | 2 0.02 46.45 Head injury | 6 0.06 46.51 Headache | 73 0.73 47.24 Hearing impaired | 4 0.04 47.28 Heart disease congenital | 3 0.03 47.31 Heart rate abnormal | 1 0.01 47.32 Heart rate decreased | 7 0.07 47.39 Heart rate increased | 11 0.11 47.50 Heart rate irregular | 3 0.03 47.53 Heart valve incompetence | 1 0.01 47.54 Heat stroke | 1 0.01 47.55 Helicobacter gastritis | 1 0.01 47.56 Helicobacter infection | 3 0.03 47.59 Hemianopia homonymous | 1 0.01 47.60 Hemiparesis | 11 0.11 47.71 Hemiplegia | 3 0.03 47.74 Henoch-Schonlein purpura | 1 0.01 47.75 Hepatic cirrhosis | 1 0.01 47.76 Hepatic cyst | 1 0.01 47.77 Hepatic encephalopathy | 3 0.03 47.80 Hepatic enzyme increased | 5 0.05 47.85 Hepatic failure | 6 0.06 47.91 Hepatic fibrosis | 1 0.01 47.92 Hepatic function abnormal | 6 0.06 47.98 Hepatic lesion | 1 0.01 47.99 Hepatic necrosis | 1 0.01 48.00 Hepatic neoplasm | 2 0.02 48.02 Hepatic pain | 1 0.01 48.03 Hepatic steatosis | 4 0.04 48.07 Hepatitis | 1 0.01 48.08 Hepatitis A antibody positive | 1 0.01 48.09 Hepatitis B | 1 0.01 48.10 Hepatitis B DNA increased | 1 0.01 48.11 Hepatitis B surface antibody positive | 1 0.01 48.12 Hepatitis C | 4 0.04 48.16 Hepatitis D | 1 0.01 48.17 Hepatitis fulminant | 1 0.01 48.18 Hepatocellular injury | 2 0.02 48.20 Hepatomegaly | 1 0.01 48.21 Hepatorenal failure | 1 0.01 48.22 Hepatotoxicity | 1 0.01 48.23 Hernia | 8 0.08 48.31 Hernia pain | 1 0.01 48.32 Herpes simplex | 1 0.01 48.33 Herpes zoster | 16 0.16 48.49 Herpes zoster oticus | 1 0.01 48.50 Heterotaxia | 1 0.01 48.51 Hiatus hernia | 7 0.07 48.58 High risk pregnancy | 1 0.01 48.59 Hip arthroplasty | 3 0.03 48.62 Hip fracture | 12 0.12 48.74 Histiocytosis haematophagic | 1 0.01 48.75 Histone antibody positive | 1 0.01 48.76 Histrionic personality disorder | 1 0.01 48.77 Homicide | 1 0.01 48.78 Hordeolum | 1 0.01 48.79 Hormone level abnormal | 3 0.03 48.82 Hospitalisation | 1 0.01 48.83 Hostility | 2 0.02 48.85 Hot flush | 12 0.12 48.97 Human bite | 1 0.01 48.98 Human polyomavirus infection | 1 0.01 48.99 Humerus fracture | 1 0.01 49.00 Hydrocephalus | 5 0.05 49.05 Hydronephrosis | 4 0.04 49.09 Hyperaesthesia | 1 0.01 49.10 Hyperammonaemia | 1 0.01 49.11 Hyperbilirubinaemia | 3 0.03 49.14 Hypercalcaemia | 6 0.06 49.20 Hyperchlorhydria | 3 0.03 49.23 Hypercholesterolaemia | 3 0.03 49.26 Hypercoagulation | 3 0.03 49.29 Hypergammaglobulinaemia benign monocl.. | 1 0.01 49.30 Hyperglycaemia | 10 0.10 49.40 Hyperhidrosis | 10 0.10 49.50 Hyperkalaemia | 2 0.02 49.52 Hyperkeratosis | 1 0.01 49.53 Hyperlipidaemia | 6 0.06 49.59 Hypernatraemia | 1 0.01 49.60 Hyperparathyroidism | 1 0.01 49.61 Hyperparathyroidism secondary | 1 0.01 49.62 Hyperphagia | 2 0.02 49.64 Hyperreflexia | 1 0.01 49.65 Hypersensitivity | 15 0.15 49.80 Hypersensitivity vasculitis | 3 0.03 49.83 Hypersomnia | 3 0.03 49.86 Hypertension | 49 0.49 50.35 Hypertensive crisis | 1 0.01 50.36 Hypertensive heart disease | 1 0.01 50.37 Hyperthyroidism | 2 0.02 50.39 Hypertonia | 2 0.02 50.41 Hypertonic bladder | 2 0.02 50.43 Hypertransaminasaemia | 1 0.01 50.44 Hypertrophic scar | 1 0.01 50.45 Hyperventilation | 1 0.01 50.46 Hypoacusis | 6 0.06 50.52 Hypoaesthesia | 34 0.34 50.86 Hypoaesthesia oral | 2 0.02 50.88 Hypoalbuminaemia | 3 0.03 50.91 Hypocalcaemia | 5 0.05 50.96 Hypochloraemia | 1 0.01 50.97 Hypogammaglobulinaemia | 1 0.01 50.98 Hypoglycaemia | 2 0.02 51.00 Hypogonadism | 1 0.01 51.01 Hypokalaemia | 11 0.11 51.12 Hypokinesia | 3 0.03 51.15 Hypomagnesaemia | 4 0.04 51.19 Hyponatraemia | 4 0.04 51.23 Hypophagia | 7 0.07 51.30 Hypophosphataemia | 2 0.02 51.32 Hypoplastic left heart syndrome | 4 0.04 51.36 Hypoplastic right heart syndrome | 2 0.02 51.38 Hypopnoea | 1 0.01 51.39 Hypoproteinaemia | 1 0.01 51.40 Hyporeflexia | 1 0.01 51.41 Hyposmia | 1 0.01 51.42 Hypospadias | 4 0.04 51.46 Hypotension | 21 0.21 51.67 Hypothyroidism | 8 0.08 51.75 Hypotonia | 1 0.01 51.76 Hypoxia | 5 0.05 51.81 Hysterectomy | 3 0.03 51.84 IIIrd nerve paralysis | 1 0.01 51.85 IgA nephropathy | 1 0.01 51.86 Ileostomy closure | 1 0.01 51.87 Ileus | 3 0.03 51.90 Ileus paralytic | 1 0.01 51.91 Ill-defined disorder | 7 0.07 51.98 Immune reconstitution inflammatory sy.. | 7 0.07 52.05 Immune system disorder | 2 0.02 52.07 Immune thrombocytopenic purpura | 2 0.02 52.09 Immunodeficiency | 2 0.02 52.11 Impaired driving ability | 4 0.04 52.15 Impaired gastric emptying | 1 0.01 52.16 Impaired healing | 10 0.10 52.26 Impaired self-care | 2 0.02 52.28 Impaired work ability | 2 0.02 52.30 Inadequate analgesia | 3 0.03 52.33 Inappropriate antidiuretic hormone se.. | 1 0.01 52.34 Inappropriate schedule of drug admini.. | 9 0.09 52.43 Incision site infection | 2 0.02 52.45 Incision site pain | 1 0.01 52.46 Incisional hernia | 1 0.01 52.47 Inclusion body myositis | 1 0.01 52.48 Incoherent | 1 0.01 52.49 Incontinence | 2 0.02 52.51 Incorrect dosage administered | 1 0.01 52.52 Incorrect dose administered | 8 0.08 52.60 Incorrect drug administration duration | 4 0.04 52.64 Incorrect drug administration rate | 1 0.01 52.65 Incorrect product storage | 2 0.02 52.67 Incorrect route of drug administration | 2 0.02 52.69 Increased appetite | 3 0.03 52.72 Increased tendency to bruise | 1 0.01 52.73 Increased upper airway secretion | 1 0.01 52.74 Induration | 1 0.01 52.75 Infarction | 1 0.01 52.76 Infected bites | 1 0.01 52.77 Infected skin ulcer | 1 0.01 52.78 Infection | 15 0.15 52.93 Infectious pleural effusion | 1 0.01 52.94 Infertility | 1 0.01 52.95 Inflammation | 9 0.09 53.04 Inflammatory bowel disease | 60 0.60 53.64 Influenza | 25 0.25 53.89 Influenza like illness | 16 0.16 54.05 Infusion related reaction | 12 0.12 54.17 Infusion site pain | 1 0.01 54.18 Ingrowing nail | 1 0.01 54.19 Inguinal hernia | 2 0.02 54.21 Inguinal mass | 1 0.01 54.22 Injection site bruising | 9 0.09 54.31 Injection site discolouration | 1 0.01 54.32 Injection site dysaesthesia | 1 0.01 54.33 Injection site erythema | 7 0.07 54.40 Injection site extravasation | 1 0.01 54.41 Injection site haemorrhage | 4 0.04 54.45 Injection site induration | 2 0.02 54.47 Injection site injury | 1 0.01 54.48 Injection site laceration | 1 0.01 54.49 Injection site mass | 1 0.01 54.50 Injection site oedema | 1 0.01 54.51 Injection site pain | 27 0.27 54.78 Injection site pruritus | 3 0.03 54.81 Injection site rash | 1 0.01 54.82 Injection site reaction | 2 0.02 54.84 Injection site swelling | 7 0.07 54.91 Injection site urticaria | 1 0.01 54.92 Injection site warmth | 2 0.02 54.94 Injury | 43 0.43 55.37 Injury associated with device | 3 0.03 55.40 Inner ear disorder | 1 0.01 55.41 Insomnia | 40 0.40 55.81 Intentional overdose | 2 0.02 55.83 Intentional product misuse | 66 0.66 56.49 Intentional product use issue | 7 0.07 56.56 Intentional self-injury | 1 0.01 56.57 Internal injury | 3 0.03 56.60 International normalised ratio increa.. | 3 0.03 56.63 Interruption of aortic arch | 1 0.01 56.64 Interstitial lung disease | 4 0.04 56.68 Intervertebral disc compression | 1 0.01 56.69 Intervertebral disc degeneration | 8 0.08 56.77 Intervertebral disc disorder | 3 0.03 56.80 Intervertebral disc displacement | 1 0.01 56.81 Intervertebral disc operation | 1 0.01 56.82 Intervertebral disc protrusion | 10 0.10 56.92 Intestinal haemorrhage | 11 0.11 57.03 Intestinal infarction | 1 0.01 57.04 Intestinal obstruction | 21 0.21 57.25 Intestinal perforation | 4 0.04 57.29 Intra-abdominal haemorrhage | 1 0.01 57.30 Intracardiac thrombus | 2 0.02 57.32 Intracranial aneurysm | 3 0.03 57.35 Intracranial pressure increased | 1 0.01 57.36 Intracranial tumour haemorrhage | 1 0.01 57.37 Intraductal proliferative breast lesion | 1 0.01 57.38 Intramedullary rod insertion | 11 0.11 57.49 Intraocular pressure fluctuation | 1 0.01 57.50 Intraocular pressure increased | 4 0.04 57.54 Intraocular pressure test abnormal | 1 0.01 57.55 Invasive breast carcinoma | 1 0.01 57.56 Invasive ductal breast carcinoma | 2 0.02 57.58 Iron deficiency | 2 0.02 57.60 Iron deficiency anaemia | 2 0.02 57.62 Irritability | 3 0.03 57.65 Irritable bowel syndrome | 52 0.52 58.17 Ischaemic cerebral infarction | 1 0.01 58.18 Ischaemic stroke | 3 0.03 58.21 Jaundice | 2 0.02 58.23 Joint dislocation | 8 0.08 58.31 Joint effusion | 3 0.03 58.34 Joint injury | 4 0.04 58.38 Joint lock | 1 0.01 58.39 Joint stiffness | 5 0.05 58.44 Joint swelling | 12 0.12 58.56 Junctional ectopic tachycardia | 1 0.01 58.57 Juvenile idiopathic arthritis | 1 0.01 58.58 K-ras gene mutation | 1 0.01 58.59 Kaposi's sarcoma | 1 0.01 58.60 Kaposi's sarcoma AIDS related | 1 0.01 58.61 Kawasaki's disease | 1 0.01 58.62 Keratoacanthoma | 2 0.02 58.64 Ketonuria | 1 0.01 58.65 Kidney fibrosis | 1 0.01 58.66 Kidney infection | 6 0.06 58.72 Kidney rupture | 1 0.01 58.73 Kidney transplant rejection | 5 0.05 58.78 Klebsiella infection | 2 0.02 58.80 Klebsiella sepsis | 1 0.01 58.81 Knee arthroplasty | 7 0.07 58.88 Knee deformity | 2 0.02 58.90 Knee operation | 3 0.03 58.93 Kussmaul respiration | 1 0.01 58.94 Kyphosis | 3 0.03 58.97 Labile blood pressure | 1 0.01 58.98 Labile hypertension | 1 0.01 58.99 Laboratory test abnormal | 5 0.05 59.04 Labour complication | 1 0.01 59.05 Labyrinthitis | 2 0.02 59.07 Laceration | 3 0.03 59.10 Lacrimation increased | 3 0.03 59.13 Lactic acidosis | 2 0.02 59.15 Language disorder | 2 0.02 59.17 Large for dates baby | 2 0.02 59.19 Large intestinal haemorrhage | 1 0.01 59.20 Large intestinal ulcer | 2 0.02 59.22 Large intestine perforation | 3 0.03 59.25 Large intestine polyp | 11 0.11 59.36 Laryngeal oedema | 1 0.01 59.37 Laryngitis | 3 0.03 59.40 Laryngomalacia | 1 0.01 59.41 Larynx irritation | 1 0.01 59.42 Lateral medullary syndrome | 1 0.01 59.43 Laziness | 1 0.01 59.44 Learning disorder | 1 0.01 59.45 Left ventricular dysfunction | 1 0.01 59.46 Left ventricular hypertrophy | 2 0.02 59.48 Lethargy | 6 0.06 59.54 Leukaemia | 2 0.02 59.56 Leukaemoid reaction | 1 0.01 59.57 Leukocytosis | 3 0.03 59.60 Leukoencephalopathy | 2 0.02 59.62 Leukopenia | 13 0.13 59.75 Libido decreased | 5 0.05 59.80 Libido increased | 1 0.01 59.81 Ligament disorder | 1 0.01 59.82 Ligament injury | 1 0.01 59.83 Ligament rupture | 1 0.01 59.84 Ligament sprain | 4 0.04 59.88 Light chain analysis increased | 1 0.01 59.89 Limb asymmetry | 3 0.03 59.92 Limb deformity | 3 0.03 59.95 Limb discomfort | 7 0.07 60.02 Limb injury | 10 0.10 60.12 Limb malformation | 1 0.01 60.13 Limb operation | 1 0.01 60.14 Limb reduction defect | 1 0.01 60.15 Lip disorder | 2 0.02 60.17 Lip dry | 6 0.06 60.23 Lip exfoliation | 1 0.01 60.24 Lip oedema | 1 0.01 60.25 Lip pain | 2 0.02 60.27 Lip squamous cell carcinoma | 1 0.01 60.28 Lip swelling | 2 0.02 60.30 Lipase increased | 1 0.01 60.31 Lipodystrophy acquired | 1 0.01 60.32 Lipoma | 1 0.01 60.33 Live birth | 1 0.01 60.34 Liver disorder | 9 0.09 60.43 Liver function test abnormal | 2 0.02 60.45 Liver injury | 8 0.08 60.53 Living in residential institution | 1 0.01 60.54 Localised infection | 7 0.07 60.61 Localised oedema | 1 0.01 60.62 Loss of consciousness | 12 0.12 60.74 Loss of control of legs | 1 0.01 60.75 Loss of employment | 2 0.02 60.77 Loss of libido | 2 0.02 60.79 Loss of proprioception | 1 0.01 60.80 Low birth weight baby | 2 0.02 60.82 Low density lipoprotein increased | 2 0.02 60.84 Low turnover osteopathy | 10 0.10 60.94 Lower extremity mass | 2 0.02 60.96 Lower gastrointestinal haemorrhage | 1 0.01 60.97 Lower limb fracture | 6 0.06 61.03 Lower respiratory tract infection | 2 0.02 61.05 Lower respiratory tract infection fun.. | 1 0.01 61.06 Lumbar vertebral fracture | 2 0.02 61.08 Lung adenocarcinoma | 1 0.01 61.09 Lung carcinoma cell type unspecified .. | 1 0.01 61.10 Lung consolidation | 1 0.01 61.11 Lung disorder | 9 0.09 61.20 Lung infection | 6 0.06 61.26 Lung infiltration | 1 0.01 61.27 Lung neoplasm malignant | 4 0.04 61.31 Lung transplant | 1 0.01 61.32 Lupus-like syndrome | 2 0.02 61.34 Lymph node pain | 1 0.01 61.35 Lymphadenopathy | 6 0.06 61.41 Lymphatic system neoplasm | 1 0.01 61.42 Lymphocele | 2 0.02 61.44 Lymphocyte count abnormal | 1 0.01 61.45 Lymphocyte count decreased | 7 0.07 61.52 Lymphocyte count increased | 2 0.02 61.54 Lymphocytic infiltration | 1 0.01 61.55 Lymphoedema | 3 0.03 61.58 Lymphoma | 2 0.02 61.60 Lymphopenia | 1 0.01 61.61 Macrocytosis | 1 0.01 61.62 Macular degeneration | 2 0.02 61.64 Macular hole | 1 0.01 61.65 Maculopathy | 1 0.01 61.66 Madarosis | 1 0.01 61.67 Malaise | 96 0.96 62.63 Malignant melanoma | 4 0.04 62.67 Malignant melanoma stage IV | 1 0.01 62.68 Malignant neoplasm progression | 17 0.17 62.85 Malnutrition | 3 0.03 62.88 Mania | 1 0.01 62.89 Masked facies | 1 0.01 62.90 Mass | 4 0.04 62.94 Mastication disorder | 1 0.01 62.95 Mastitis | 2 0.02 62.97 Maternal exposure before pregnancy | 1 0.01 62.98 Maternal exposure during pregnancy | 5 0.05 63.03 Maternal exposure timing unspecified | 5 0.05 63.08 May-Thurner syndrome | 1 0.01 63.09 Mean cell haemoglobin concentration d.. | 1 0.01 63.10 Mean cell haemoglobin increased | 1 0.01 63.11 Mean cell volume abnormal | 1 0.01 63.12 Mean cell volume increased | 3 0.03 63.15 Meconium in amniotic fluid | 3 0.03 63.18 Meconium stain | 1 0.01 63.19 Mediastinal mass | 1 0.01 63.20 Medical device discomfort | 2 0.02 63.22 Medical device removal | 1 0.01 63.23 Medication error | 3 0.03 63.26 Medication overuse headache | 1 0.01 63.27 Melaena | 3 0.03 63.30 Melanocytic naevus | 1 0.01 63.31 Memory impairment | 36 0.36 63.67 Meniere's disease | 1 0.01 63.68 Meningioma | 2 0.02 63.70 Meningioma benign | 1 0.01 63.71 Meningitis aseptic | 1 0.01 63.72 Meningitis meningococcal | 2 0.02 63.74 Meningococcal infection | 2 0.02 63.76 Meningococcal sepsis | 4 0.04 63.80 Meningomyelocele | 2 0.02 63.82 Meniscus injury | 5 0.05 63.87 Menopausal symptoms | 1 0.01 63.88 Menopause | 1 0.01 63.89 Menorrhagia | 2 0.02 63.91 Menstrual disorder | 2 0.02 63.93 Menstruation delayed | 2 0.02 63.95 Menstruation irregular | 1 0.01 63.96 Mental disorder | 11 0.11 64.07 Mental impairment | 6 0.06 64.13 Mental retardation | 1 0.01 64.14 Mental status changes | 3 0.03 64.17 Meralgia paraesthetica | 1 0.01 64.18 Metabolic acidosis | 1 0.01 64.19 Metastases to bone | 2 0.02 64.21 Metastases to liver | 2 0.02 64.23 Metastases to lung | 2 0.02 64.25 Metastases to lymph nodes | 2 0.02 64.27 Metastases to peritoneum | 1 0.01 64.28 Metastases to skin | 1 0.01 64.29 Metastases to spine | 1 0.01 64.30 Metastasis | 1 0.01 64.31 Metastatic neoplasm | 1 0.01 64.32 Metastatic renal cell carcinoma | 2 0.02 64.34 Microcephaly | 3 0.03 64.37 Microcytic anaemia | 1 0.01 64.38 Micrognathia | 1 0.01 64.39 Micropenis | 1 0.01 64.40 Mid-life crisis | 1 0.01 64.41 Migraine | 18 0.18 64.59 Miliaria | 1 0.01 64.60 Mitochondrial cytopathy | 1 0.01 64.61 Mitral valve atresia | 1 0.01 64.62 Mitral valve incompetence | 5 0.05 64.67 Mitral valve prolapse | 1 0.01 64.68 Mobility decreased | 18 0.18 64.86 Monoclonal immunoglobulin present | 1 0.01 64.87 Monocytosis | 1 0.01 64.88 Monoparesis | 1 0.01 64.89 Monoplegia | 1 0.01 64.90 Mood altered | 2 0.02 64.92 Mood swings | 6 0.06 64.98 Morbid thoughts | 1 0.01 64.99 Motor dysfunction | 1 0.01 65.00 Mouth haemorrhage | 1 0.01 65.01 Mouth swelling | 1 0.01 65.02 Movement disorder | 3 0.03 65.05 Mucosal haemorrhage | 1 0.01 65.06 Mucosal inflammation | 7 0.07 65.13 Multi-organ disorder | 1 0.01 65.14 Multi-organ failure | 8 0.08 65.22 Multiple allergies | 5 0.05 65.27 Multiple fractures | 2 0.02 65.29 Multiple injuries | 7 0.07 65.36 Multiple sclerosis | 11 0.11 65.47 Multiple sclerosis relapse | 21 0.21 65.68 Multiple-drug resistance | 1 0.01 65.69 Muscle atrophy | 6 0.06 65.75 Muscle disorder | 3 0.03 65.78 Muscle enzyme increased | 1 0.01 65.79 Muscle fatigue | 1 0.01 65.80 Muscle rupture | 1 0.01 65.81 Muscle spasms | 22 0.22 66.03 Muscle spasticity | 5 0.05 66.08 Muscle strain | 4 0.04 66.12 Muscle tightness | 1 0.01 66.13 Muscle twitching | 2 0.02 66.15 Muscular weakness | 25 0.25 66.40 Musculoskeletal chest pain | 5 0.05 66.45 Musculoskeletal discomfort | 7 0.07 66.52 Musculoskeletal disorder | 11 0.11 66.63 Musculoskeletal pain | 18 0.18 66.81 Musculoskeletal stiffness | 7 0.07 66.88 Myalgia | 17 0.17 67.05 Myasthenia gravis | 2 0.02 67.07 Mycobacterium fortuitum infection | 1 0.01 67.08 Mycosis fungoides | 1 0.01 67.09 Mydriasis | 1 0.01 67.10 Myelodysplastic syndrome | 2 0.02 67.12 Myelofibrosis | 1 0.01 67.13 Myelopathy | 1 0.01 67.14 Myocardial fibrosis | 1 0.01 67.15 Myocardial infarction | 27 0.27 67.42 Myocardial ischaemia | 2 0.02 67.44 Myocardial necrosis marker increased | 2 0.02 67.46 Myoclonus | 3 0.03 67.49 Myoglobin blood increased | 1 0.01 67.50 Myopathy | 1 0.01 67.51 Myositis | 1 0.01 67.52 Nail discolouration | 2 0.02 67.54 Nail injury | 1 0.01 67.55 Narcolepsy | 2 0.02 67.57 Nasal abscess | 1 0.01 67.58 Nasal congestion | 3 0.03 67.61 Nasal dryness | 3 0.03 67.64 Nasal inflammation | 1 0.01 67.65 Nasal mucosal disorder | 1 0.01 67.66 Nasal septum deviation | 1 0.01 67.67 Nasopharyngitis | 21 0.21 67.88 Nausea | 78 0.78 68.66 Neck injury | 1 0.01 68.67 Neck pain | 8 0.08 68.75 Necrosis | 2 0.02 68.77 Necrotising fasciitis | 2 0.02 68.79 Needle issue | 1 0.01 68.80 Neonatal aspiration | 1 0.01 68.81 Neonatal respiratory distress syndrome | 3 0.03 68.84 Neoplasm | 1 0.01 68.85 Neoplasm malignant | 12 0.12 68.97 Neoplasm progression | 3 0.03 69.00 Nephrectomy | 1 0.01 69.01 Nephrolithiasis | 6 0.06 69.07 Nephropathy | 1 0.01 69.08 Nephropathy toxic | 2 0.02 69.10 Nerve compression | 1 0.01 69.11 Nerve conduction studies abnormal | 1 0.01 69.12 Nerve injury | 11 0.11 69.23 Nervous system disorder | 7 0.07 69.30 Nervousness | 9 0.09 69.39 Neural tube defect | 1 0.01 69.40 Neuralgia | 6 0.06 69.46 Neuroendocrine tumour | 1 0.01 69.47 Neurogenic bladder | 1 0.01 69.48 Neurogenic bowel | 1 0.01 69.49 Neurogenic shock | 1 0.01 69.50 Neuroleptic malignant syndrome | 2 0.02 69.52 Neurological decompensation | 1 0.01 69.53 Neurological infection | 1 0.01 69.54 Neurological symptom | 3 0.03 69.57 Neuromyelitis optica | 1 0.01 69.58 Neuropathy peripheral | 18 0.18 69.76 Neurotoxicity | 6 0.06 69.82 Neutralising antibodies positive | 1 0.01 69.83 Neutropenia | 25 0.25 70.08 Neutropenic sepsis | 4 0.04 70.12 Neutrophil count decreased | 7 0.07 70.19 Neutrophil count increased | 4 0.04 70.23 Night sweats | 2 0.02 70.25 Nightmare | 5 0.05 70.30 No adverse event | 1 0.01 70.31 No therapeutic response | 3 0.03 70.34 Nocturia | 4 0.04 70.38 Nodal rhythm | 1 0.01 70.39 Nodule | 2 0.02 70.41 Non-Hodgkin's lymphoma | 1 0.01 70.42 Non-cardiac chest pain | 3 0.03 70.45 Non-small cell lung cancer | 2 0.02 70.47 Nonreassuring foetal heart rate pattern | 1 0.01 70.48 Nonspecific reaction | 1 0.01 70.49 Normal pressure hydrocephalus | 1 0.01 70.50 Norovirus test positive | 1 0.01 70.51 Nosocomial infection | 2 0.02 70.53 Nystagmus | 2 0.02 70.55 Obesity | 2 0.02 70.57 Obsessive-compulsive disorder | 1 0.01 70.58 Ocular discomfort | 1 0.01 70.59 Ocular hyperaemia | 5 0.05 70.64 Ocular neoplasm | 1 0.01 70.65 Ocular vasculitis | 1 0.01 70.66 Oculomucocutaneous syndrome | 1 0.01 70.67 Odynophagia | 1 0.01 70.68 Oedema | 7 0.07 70.75 Oedema peripheral | 11 0.11 70.86 Oesophageal adenocarcinoma | 1 0.01 70.87 Oesophageal candidiasis | 2 0.02 70.89 Oesophageal carcinoma | 3 0.03 70.92 Oesophageal discomfort | 1 0.01 70.93 Oesophageal disorder | 3 0.03 70.96 Oesophageal dysplasia | 1 0.01 70.97 Oesophageal haemorrhage | 1 0.01 70.98 Oesophageal obstruction | 2 0.02 71.00 Oesophageal pain | 3 0.03 71.03 Oesophageal spasm | 1 0.01 71.04 Oesophageal ulcer | 2 0.02 71.06 Oesophageal varices haemorrhage | 1 0.01 71.07 Oesophagitis | 3 0.03 71.10 Off label use | 125 1.25 72.35 Oligodendroglioma benign | 1 0.01 72.36 Oligohydramnios | 5 0.05 72.41 Oligomenorrhoea | 1 0.01 72.42 Onychomadesis | 2 0.02 72.44 Oophoritis | 1 0.01 72.45 Open fracture | 1 0.01 72.46 Open reduction of fracture | 1 0.01 72.47 Opiates positive | 1 0.01 72.48 Optic nerve disorder | 1 0.01 72.49 Optic nerve injury | 1 0.01 72.50 Optic neuritis | 3 0.03 72.53 Optic neuropathy | 1 0.01 72.54 Oral candidiasis | 1 0.01 72.55 Oral discomfort | 2 0.02 72.57 Oral disorder | 1 0.01 72.58 Oral herpes | 2 0.02 72.60 Oral infection | 1 0.01 72.61 Oral mucosal blistering | 4 0.04 72.65 Oral mucosal exfoliation | 1 0.01 72.66 Orchitis | 1 0.01 72.67 Organising pneumonia | 1 0.01 72.68 Oropharyngeal candidiasis | 1 0.01 72.69 Oropharyngeal discomfort | 3 0.03 72.72 Oropharyngeal pain | 15 0.15 72.87 Orthostatic hypotension | 6 0.06 72.93 Osteoarthritis | 17 0.17 73.10 Osteolysis | 1 0.01 73.11 Osteomyelitis | 5 0.05 73.16 Osteomyelitis bacterial | 1 0.01 73.17 Osteomyelitis viral | 1 0.01 73.18 Osteonecrosis | 7 0.07 73.25 Osteonecrosis of jaw | 5 0.05 73.30 Osteopenia | 6 0.06 73.36 Osteoporosis | 12 0.12 73.48 Otitis externa | 1 0.01 73.49 Otitis media | 2 0.02 73.51 Ototoxicity | 1 0.01 73.52 Ovarian cancer | 1 0.01 73.53 Ovarian cyst | 3 0.03 73.56 Ovarian fibroma | 1 0.01 73.57 Overdose | 13 0.13 73.70 Overweight | 2 0.02 73.72 Oxygen saturation decreased | 1 0.01 73.73 Oxygen supplementation | 1 0.01 73.74 PO2 decreased | 1 0.01 73.75 Packed red blood cell transfusion | 1 0.01 73.76 Pain | 126 1.26 75.02 Pain in extremity | 56 0.56 75.58 Pain in jaw | 2 0.02 75.60 Pain of skin | 2 0.02 75.62 Pallor | 3 0.03 75.65 Palmar erythema | 1 0.01 75.66 Palmar-plantar erythrodysaesthesia sy.. | 4 0.04 75.70 Palpitations | 21 0.21 75.91 Pancreatitis | 7 0.07 75.98 Pancreatitis acute | 2 0.02 76.00 Pancreatitis chronic | 1 0.01 76.01 Pancytopenia | 10 0.10 76.11 Panic attack | 7 0.07 76.18 Panic disorder | 1 0.01 76.19 Papillary thyroid cancer | 1 0.01 76.20 Papilloedema | 3 0.03 76.23 Papilloma viral infection | 1 0.01 76.24 Papule | 1 0.01 76.25 Paraesthesia | 19 0.19 76.44 Paraesthesia oral | 1 0.01 76.45 Paralysis | 3 0.03 76.48 Paranasal sinus hypersecretion | 1 0.01 76.49 Paranoia | 8 0.08 76.57 Paranoid personality disorder | 1 0.01 76.58 Paraplegia | 2 0.02 76.60 Parathyroid hormone-related protein i.. | 1 0.01 76.61 Paresis | 1 0.01 76.62 Parkinson's disease | 2 0.02 76.64 Paronychia | 3 0.03 76.67 Patent ductus arteriosus | 14 0.14 76.81 Pathological fracture | 2 0.02 76.83 Pathological gambling | 1 0.01 76.84 Pelvic congestion | 1 0.01 76.85 Pelvic fracture | 7 0.07 76.92 Pelvic haemorrhage | 1 0.01 76.93 Pelvic inflammatory disease | 3 0.03 76.96 Pelvic mass | 1 0.01 76.97 Pelvic organ injury | 1 0.01 76.98 Pelvic pain | 4 0.04 77.02 Pelvic venous thrombosis | 1 0.01 77.03 Penile size reduced | 1 0.01 77.04 Penis disorder | 1 0.01 77.05 Peptic ulcer | 1 0.01 77.06 Peptic ulcer perforation | 1 0.01 77.07 Performance status decreased | 1 0.01 77.08 Pericardial effusion | 9 0.09 77.17 Pericardial haemorrhage | 1 0.01 77.18 Pericarditis | 4 0.04 77.22 Perineal abscess | 1 0.01 77.23 Perinephric collection | 1 0.01 77.24 Periodontitis | 2 0.02 77.26 Peripheral arterial occlusive disease | 1 0.01 77.27 Peripheral coldness | 3 0.03 77.30 Peripheral ischaemia | 3 0.03 77.33 Peripheral sensory neuropathy | 1 0.01 77.34 Peripheral swelling | 25 0.25 77.59 Perirectal abscess | 1 0.01 77.60 Peritoneal tuberculosis | 1 0.01 77.61 Peritonitis | 3 0.03 77.64 Peroneal nerve palsy | 4 0.04 77.68 Persistent foetal circulation | 4 0.04 77.72 Personality change | 1 0.01 77.73 Petit mal epilepsy | 2 0.02 77.75 Peyronie's disease | 1 0.01 77.76 Pharyngeal disorder | 2 0.02 77.78 Pharyngeal oedema | 1 0.01 77.79 Pharyngitis | 5 0.05 77.84 Pharyngitis streptococcal | 3 0.03 77.87 Phlebitis | 1 0.01 77.88 Photosensitivity reaction | 4 0.04 77.92 Physical disability | 4 0.04 77.96 Pica | 1 0.01 77.97 Pierre Robin syndrome | 1 0.01 77.98 Pilonidal cyst | 1 0.01 77.99 Pituitary tumour recurrent | 1 0.01 78.00 Plantar fasciitis | 3 0.03 78.03 Plasma cell myeloma | 11 0.11 78.14 Platelet count decreased | 17 0.17 78.31 Platelet count increased | 1 0.01 78.32 Platelet transfusion | 1 0.01 78.33 Pleural effusion | 17 0.17 78.50 Pneumocystis jirovecii infection | 1 0.01 78.51 Pneumocystis jirovecii pneumonia | 2 0.02 78.53 Pneumonia | 55 0.55 79.08 Pneumonia aspiration | 2 0.02 79.10 Pneumonia bacterial | 2 0.02 79.12 Pneumonia staphylococcal | 1 0.01 79.13 Pneumonitis | 2 0.02 79.15 Pneumothorax | 3 0.03 79.18 Pollakiuria | 7 0.07 79.25 Polyarthritis | 2 0.02 79.27 Polydipsia | 1 0.01 79.28 Polymenorrhoea | 2 0.02 79.30 Polymyalgia rheumatica | 1 0.01 79.31 Polyomavirus-associated nephropathy | 1 0.01 79.32 Polyuria | 1 0.01 79.33 Poor peripheral circulation | 3 0.03 79.36 Poor quality drug administered | 3 0.03 79.39 Post herpetic neuralgia | 1 0.01 79.40 Post procedural complication | 4 0.04 79.44 Post procedural haematoma | 1 0.01 79.45 Post procedural haemorrhage | 4 0.04 79.49 Post procedural infection | 2 0.02 79.51 Post procedural oedema | 1 0.01 79.52 Post procedural pulmonary embolism | 1 0.01 79.53 Post transplant lymphoproliferative d.. | 1 0.01 79.54 Post-traumatic epilepsy | 1 0.01 79.55 Post-traumatic neck syndrome | 1 0.01 79.56 Post-traumatic pain | 1 0.01 79.57 Post-traumatic stress disorder | 6 0.06 79.63 Postoperative fever | 2 0.02 79.65 Postoperative wound infection | 3 0.03 79.68 Posturing | 1 0.01 79.69 Pouchitis | 1 0.01 79.70 Pre-eclampsia | 1 0.01 79.71 Precancerous cells present | 1 0.01 79.72 Pregnancy | 1 0.01 79.73 Pregnancy on oral contraceptive | 2 0.02 79.75 Pregnancy test positive | 1 0.01 79.76 Pregnancy with contraceptive device | 2 0.02 79.78 Premature baby | 14 0.14 79.92 Premature delivery | 1 0.01 79.93 Premature labour | 2 0.02 79.95 Prerenal failure | 1 0.01 79.96 Presbyoesophagus | 1 0.01 79.97 Prescribed overdose | 2 0.02 79.99 Presyncope | 5 0.05 80.04 Priapism | 1 0.01 80.05 Procedural anxiety | 2 0.02 80.07 Procedural haemorrhage | 2 0.02 80.09 Procedural pain | 6 0.06 80.15 Proctitis | 1 0.01 80.16 Proctitis ulcerative | 2 0.02 80.18 Product adhesion issue | 1 0.01 80.19 Product blister packaging issue | 1 0.01 80.20 Product name confusion | 1 0.01 80.21 Product packaging issue | 1 0.01 80.22 Product packaging quantity issue | 1 0.01 80.23 Product physical issue | 1 0.01 80.24 Product quality issue | 26 0.26 80.50 Product substitution issue | 3 0.03 80.53 Product taste abnormal | 1 0.01 80.54 Product use issue | 26 0.26 80.80 Productive cough | 10 0.10 80.90 Progressive multifocal leukoencephalo.. | 7 0.07 80.97 Prostate cancer | 4 0.04 81.01 Prostate cancer recurrent | 1 0.01 81.02 Prostatic specific antigen increased | 1 0.01 81.03 Prostatitis | 2 0.02 81.05 Protein total abnormal | 1 0.01 81.06 Protein total increased | 1 0.01 81.07 Protein urine present | 2 0.02 81.09 Proteinuria | 2 0.02 81.11 Proteus test positive | 1 0.01 81.12 Prothrombin time prolonged | 1 0.01 81.13 Pruritus | 34 0.34 81.47 Pruritus generalised | 1 0.01 81.48 Pseudomonas bronchitis | 1 0.01 81.49 Psoriasis | 11 0.11 81.60 Psoriatic arthropathy | 3 0.03 81.63 Psychogenic pain disorder | 1 0.01 81.64 Psychological trauma | 7 0.07 81.71 Psychomotor hyperactivity | 2 0.02 81.73 Psychotic disorder | 5 0.05 81.78 Pubis fracture | 1 0.01 81.79 Pulmonary arterial hypertension | 13 0.13 81.92 Pulmonary artery atresia | 3 0.03 81.95 Pulmonary artery stenosis | 1 0.01 81.96 Pulmonary congestion | 1 0.01 81.97 Pulmonary embolism | 26 0.26 82.23 Pulmonary fibrosis | 4 0.04 82.27 Pulmonary function test decreased | 1 0.01 82.28 Pulmonary granuloma | 1 0.01 82.29 Pulmonary hypertension | 38 0.38 82.67 Pulmonary infarction | 2 0.02 82.69 Pulmonary mass | 2 0.02 82.71 Pulmonary oedema | 9 0.09 82.80 Pulmonary thrombosis | 1 0.01 82.81 Pulmonary tuberculosis | 2 0.02 82.83 Pulmonary valve incompetence | 1 0.01 82.84 Pulmonary valve stenosis | 6 0.06 82.90 Pulmonary valve stenosis congenital | 2 0.02 82.92 Pulmonary veno-occlusive disease | 1 0.01 82.93 Pulse absent | 1 0.01 82.94 Pupillary light reflex tests abnormal | 1 0.01 82.95 Pupils unequal | 1 0.01 82.96 Purpura | 1 0.01 82.97 Pyelonephritis | 4 0.04 83.01 Pyoderma gangrenosum | 1 0.01 83.02 Pyrexia | 54 0.54 83.56 Quadriparesis | 1 0.01 83.57 Quality of life decreased | 3 0.03 83.60 Radiation injury | 1 0.01 83.61 Radiation skin injury | 1 0.01 83.62 Radiculopathy | 2 0.02 83.64 Radius fracture | 1 0.01 83.65 Rash | 42 0.42 84.07 Rash erythematous | 5 0.05 84.12 Rash generalised | 4 0.04 84.16 Rash macular | 2 0.02 84.18 Rash papular | 2 0.02 84.20 Rash pruritic | 7 0.07 84.27 Raynaud's phenomenon | 1 0.01 84.28 Reading disorder | 1 0.01 84.29 Rebound effect | 1 0.01 84.30 Rectal cancer | 1 0.01 84.31 Rectal haemorrhage | 10 0.10 84.41 Rectal obstruction | 1 0.01 84.42 Rectal perforation | 1 0.01 84.43 Rectal polyp | 1 0.01 84.44 Rectal prolapse | 1 0.01 84.45 Rectal tenesmus | 1 0.01 84.46 Rectal ulcer | 1 0.01 84.47 Rectocele | 2 0.02 84.49 Rectourethral fistula | 1 0.01 84.50 Red blood cell count decreased | 5 0.05 84.55 Red blood cell sedimentation rate inc.. | 1 0.01 84.56 Red blood cells urine positive | 1 0.01 84.57 Red cell distribution width increased | 1 0.01 84.58 Reflux gastritis | 1 0.01 84.59 Regurgitation | 6 0.06 84.65 Renal aplasia | 1 0.01 84.66 Renal artery stenosis | 1 0.01 84.67 Renal cancer | 1 0.01 84.68 Renal cell carcinoma | 4 0.04 84.72 Renal cell carcinoma stage I | 1 0.01 84.73 Renal cyst | 2 0.02 84.75 Renal disorder | 6 0.06 84.81 Renal failure | 23 0.23 85.04 Renal function test abnormal | 1 0.01 85.05 Renal haemorrhage | 1 0.01 85.06 Renal impairment | 7 0.07 85.13 Renal injury | 1 0.01 85.14 Renal mass | 1 0.01 85.15 Renal pain | 3 0.03 85.18 Renal tubular atrophy | 1 0.01 85.19 Renal tubular disorder | 1 0.01 85.20 Renal tubular necrosis | 1 0.01 85.21 Respiratory arrest | 2 0.02 85.23 Respiratory depression | 2 0.02 85.25 Respiratory disorder | 6 0.06 85.31 Respiratory distress | 6 0.06 85.37 Respiratory failure | 13 0.13 85.50 Respiratory gas exchange disorder | 1 0.01 85.51 Respiratory moniliasis | 1 0.01 85.52 Respiratory rate increased | 2 0.02 85.54 Respiratory tract congestion | 3 0.03 85.57 Respiratory tract infection | 1 0.01 85.58 Respiratory tract infection fungal | 1 0.01 85.59 Restless legs syndrome | 3 0.03 85.62 Restlessness | 5 0.05 85.67 Retching | 6 0.06 85.73 Retinal haemorrhage | 1 0.01 85.74 Retroperitoneal haematoma | 2 0.02 85.76 Rhabdomyolysis | 3 0.03 85.79 Rhabdomyosarcoma | 1 0.01 85.80 Rheumatic disorder | 1 0.01 85.81 Rheumatoid arthritis | 13 0.13 85.94 Rhinitis | 1 0.01 85.95 Rhinitis allergic | 2 0.02 85.97 Rhinorrhoea | 8 0.08 86.05 Rhinovirus infection | 1 0.01 86.06 Rib deformity | 1 0.01 86.07 Rib fracture | 5 0.05 86.12 Right aortic arch | 1 0.01 86.13 Right ventricular dysfunction | 1 0.01 86.14 Right ventricular failure | 3 0.03 86.17 Right ventricular hypertrophy | 2 0.02 86.19 Road traffic accident | 12 0.12 86.31 Rotator cuff repair | 1 0.01 86.32 Rotator cuff syndrome | 13 0.13 86.45 Rubber sensitivity | 2 0.02 86.47 Rubella in pregnancy | 1 0.01 86.48 Sacral hypoplasia | 1 0.01 86.49 Salivary gland mass | 1 0.01 86.50 Salivary gland operation | 1 0.01 86.51 Salivary hypersecretion | 3 0.03 86.54 Scab | 1 0.01 86.55 Scar | 7 0.07 86.62 Scar excision | 1 0.01 86.63 Schizoaffective disorder | 1 0.01 86.64 Schizophrenia | 6 0.06 86.70 Sciatica | 4 0.04 86.74 Scimitar syndrome | 1 0.01 86.75 Sclerema | 1 0.01 86.76 Scleroderma | 1 0.01 86.77 Scoliosis | 3 0.03 86.80 Scrotal disorder | 1 0.01 86.81 Scrotal ulcer | 2 0.02 86.83 Seasonal allergy | 1 0.01 86.84 Second primary malignancy | 2 0.02 86.86 Secondary hypogonadism | 1 0.01 86.87 Secondary progressive multiple sclero.. | 3 0.03 86.90 Secretion discharge | 1 0.01 86.91 Sedation | 3 0.03 86.94 Segmented hyalinising vasculitis | 1 0.01 86.95 Seizure | 30 0.30 87.25 Self esteem decreased | 1 0.01 87.26 Self-medication | 1 0.01 87.27 Semen analysis abnormal | 1 0.01 87.28 Semen volume decreased | 1 0.01 87.29 Senile osteoporosis | 1 0.01 87.30 Sensation of foreign body | 1 0.01 87.31 Sensitivity to weather change | 1 0.01 87.32 Sensory disturbance | 5 0.05 87.37 Sensory loss | 3 0.03 87.40 Sepsis | 15 0.15 87.55 Sepsis syndrome | 1 0.01 87.56 Septic shock | 9 0.09 87.65 Serratia sepsis | 1 0.01 87.66 Serum ferritin decreased | 1 0.01 87.67 Serum ferritin increased | 1 0.01 87.68 Serum sickness | 1 0.01 87.69 Sexual dysfunction | 6 0.06 87.75 Sexually transmitted disease | 1 0.01 87.76 Shone complex | 1 0.01 87.77 Shoulder dystocia | 1 0.01 87.78 Sialoadenitis | 1 0.01 87.79 Sinus arrhythmia | 1 0.01 87.80 Sinus bradycardia | 2 0.02 87.82 Sinus congestion | 1 0.01 87.83 Sinus disorder | 2 0.02 87.85 Sinus headache | 3 0.03 87.88 Sinus node dysfunction | 2 0.02 87.90 Sinus operation | 1 0.01 87.91 Sinus rhythm | 1 0.01 87.92 Sinus tachycardia | 2 0.02 87.94 Sinusitis | 16 0.16 88.10 Sinusitis bacterial | 1 0.01 88.11 Skeletal injury | 1 0.01 88.12 Skin abrasion | 1 0.01 88.13 Skin adhesion | 1 0.01 88.14 Skin atrophy | 1 0.01 88.15 Skin burning sensation | 2 0.02 88.17 Skin cancer | 1 0.01 88.18 Skin discolouration | 6 0.06 88.24 Skin disorder | 9 0.09 88.33 Skin exfoliation | 4 0.04 88.37 Skin fissures | 2 0.02 88.39 Skin hypertrophy | 1 0.01 88.40 Skin infection | 2 0.02 88.42 Skin irritation | 1 0.01 88.43 Skin lesion | 3 0.03 88.46 Skin necrosis | 1 0.01 88.47 Skin odour abnormal | 1 0.01 88.48 Skin oedema | 1 0.01 88.49 Skin papilloma | 2 0.02 88.51 Skin plaque | 3 0.03 88.54 Skin test positive | 1 0.01 88.55 Skin toxicity | 1 0.01 88.56 Skin ulcer | 5 0.05 88.61 Sleep apnoea syndrome | 1 0.01 88.62 Sleep disorder | 4 0.04 88.66 Sleep disorder due to a general medic.. | 5 0.05 88.71 Sleep disorder due to general medical.. | 5 0.05 88.76 Sleep inertia | 1 0.01 88.77 Slow response to stimuli | 1 0.01 88.78 Sluggishness | 2 0.02 88.80 Small for dates baby | 2 0.02 88.82 Small intestinal bacterial overgrowth | 1 0.01 88.83 Small intestinal obstruction | 4 0.04 88.87 Smear cervix abnormal | 1 0.01 88.88 Smooth muscle antibody positive | 1 0.01 88.89 Sneezing | 3 0.03 88.92 Social avoidant behaviour | 1 0.01 88.93 Social fear | 1 0.01 88.94 Social problem | 3 0.03 88.97 Somnambulism | 2 0.02 88.99 Somnolence | 16 0.16 89.15 Speech disorder | 16 0.16 89.31 Speech disorder developmental | 1 0.01 89.32 Spina bifida | 3 0.03 89.35 Spinal column stenosis | 9 0.09 89.44 Spinal compression fracture | 7 0.07 89.51 Spinal cord compression | 1 0.01 89.52 Spinal deformity | 2 0.02 89.54 Spinal fracture | 5 0.05 89.59 Spinal fusion surgery | 1 0.01 89.60 Spinal osteoarthritis | 5 0.05 89.65 Spinal pain | 3 0.03 89.68 Spine malformation | 1 0.01 89.69 Spondylolisthesis | 3 0.03 89.72 Spondylolysis | 1 0.01 89.73 Sputum discoloured | 2 0.02 89.75 Sputum retention | 1 0.01 89.76 Squamous cell carcinoma of skin | 1 0.01 89.77 Staphylococcal bacteraemia | 2 0.02 89.79 Staphylococcal infection | 5 0.05 89.84 Starvation | 1 0.01 89.85 Status epilepticus | 2 0.02 89.87 Stent placement | 1 0.01 89.88 Stereotypy | 1 0.01 89.89 Stevens-Johnson syndrome | 14 0.14 90.03 Stomatitis | 5 0.05 90.08 Strabismus | 1 0.01 90.09 Stress | 22 0.22 90.31 Stress cardiomyopathy | 2 0.02 90.33 Stress urinary incontinence | 1 0.01 90.34 Stupor | 2 0.02 90.36 Subacute cutaneous lupus erythematosus | 1 0.01 90.37 Subarachnoid haemorrhage | 2 0.02 90.39 Subclavian artery embolism | 1 0.01 90.40 Subclavian artery occlusion | 1 0.01 90.41 Sudden cardiac death | 5 0.05 90.46 Sudden death | 3 0.03 90.49 Suffocation feeling | 1 0.01 90.50 Suicidal ideation | 15 0.15 90.65 Suicide attempt | 4 0.04 90.69 Superinfection | 1 0.01 90.70 Superinfection viral | 1 0.01 90.71 Supraventricular tachycardia | 3 0.03 90.74 Surgery | 4 0.04 90.78 Surgical failure | 1 0.01 90.79 Suspected transmission of an infectio.. | 1 0.01 90.80 Suspiciousness | 1 0.01 90.81 Suture related complication | 1 0.01 90.82 Swelling | 10 0.10 90.92 Swelling face | 7 0.07 90.99 Swollen tongue | 1 0.01 91.00 Syncope | 25 0.25 91.25 Syndactyly | 1 0.01 91.26 Synovitis | 1 0.01 91.27 Systemic lupus erythematosus | 1 0.01 91.28 Systemic sclerosis | 1 0.01 91.29 T-cell lymphoma | 1 0.01 91.30 Tachycardia | 15 0.15 91.45 Tachypnoea | 1 0.01 91.46 Talipes | 15 0.15 91.61 Tardive dyskinesia | 2 0.02 91.63 Tearfulness | 2 0.02 91.65 Temperature intolerance | 3 0.03 91.68 Temporomandibular joint syndrome | 1 0.01 91.69 Tenderness | 2 0.02 91.71 Tendon disorder | 2 0.02 91.73 Tendon injury | 2 0.02 91.75 Tendon operation | 3 0.03 91.78 Tendon pain | 1 0.01 91.79 Tendon rupture | 11 0.11 91.90 Tendonitis | 12 0.12 92.02 Tenosynovitis | 1 0.01 92.03 Tension | 3 0.03 92.06 Tension headache | 1 0.01 92.07 Terminal state | 1 0.01 92.08 Testicular atrophy | 1 0.01 92.09 Testicular disorder | 1 0.01 92.10 Testicular infarction | 1 0.01 92.11 Testicular mass | 1 0.01 92.12 Testicular pain | 2 0.02 92.14 Tethered cord syndrome | 3 0.03 92.17 Thecal sac compression | 1 0.01 92.18 Theft | 1 0.01 92.19 Therapeutic procedure | 1 0.01 92.20 Therapeutic response decreased | 7 0.07 92.27 Therapeutic response unexpected | 7 0.07 92.34 Therapy cessation | 2 0.02 92.36 Thermal burn | 1 0.01 92.37 Thinking abnormal | 2 0.02 92.39 Throat cancer | 2 0.02 92.41 Throat irritation | 7 0.07 92.48 Throat tightness | 3 0.03 92.51 Thrombocytopenia | 24 0.24 92.75 Thrombocytosis | 1 0.01 92.76 Thrombophlebitis | 1 0.01 92.77 Thrombophlebitis superficial | 1 0.01 92.78 Thrombosis | 17 0.17 92.95 Thrombosis in device | 2 0.02 92.97 Thrombotic microangiopathy | 4 0.04 93.01 Thrombotic thrombocytopenic purpura | 3 0.03 93.04 Thyroid cancer | 3 0.03 93.07 Thyroid cancer recurrent | 1 0.01 93.08 Thyroid disorder | 6 0.06 93.14 Thyroid function test abnormal | 2 0.02 93.16 Thyroid neoplasm | 2 0.02 93.18 Thyroid operation | 1 0.01 93.19 Thyroiditis | 1 0.01 93.20 Thyroxine free abnormal | 1 0.01 93.21 Tibia fracture | 2 0.02 93.23 Tibial torsion | 1 0.01 93.24 Tinnitus | 4 0.04 93.28 Tongue biting | 1 0.01 93.29 Tongue discolouration | 1 0.01 93.30 Tongue haemorrhage | 1 0.01 93.31 Tongue pruritus | 1 0.01 93.32 Tonsillectomy | 1 0.01 93.33 Tonsillitis | 1 0.01 93.34 Tooth abscess | 2 0.02 93.36 Tooth disorder | 7 0.07 93.43 Tooth fracture | 3 0.03 93.46 Tooth infection | 2 0.02 93.48 Tooth injury | 1 0.01 93.49 Tooth loss | 2 0.02 93.51 Toothache | 2 0.02 93.53 Torsade de pointes | 2 0.02 93.55 Torticollis | 1 0.01 93.56 Total lung capacity decreased | 2 0.02 93.58 Toxic epidermal necrolysis | 5 0.05 93.63 Toxicity to various agents | 9 0.09 93.72 Toxoplasmosis | 1 0.01 93.73 Tracheal ulcer | 1 0.01 93.74 Tracheomalacia | 2 0.02 93.76 Transaminases increased | 2 0.02 93.78 Transfusion | 1 0.01 93.79 Transient ischaemic attack | 6 0.06 93.85 Transient tachypnoea of the newborn | 2 0.02 93.87 Transplant rejection | 2 0.02 93.89 Transplantation complication | 1 0.01 93.90 Transposition of the great vessels | 4 0.04 93.94 Transurethral prostatectomy | 1 0.01 93.95 Traumatic lung injury | 2 0.02 93.97 Treatment failure | 2 0.02 93.99 Treatment noncompliance | 3 0.03 94.02 Tremor | 29 0.29 94.31 Trichorrhexis | 1 0.01 94.32 Tricuspid valve incompetence | 4 0.04 94.36 Tricuspid valve stenosis | 1 0.01 94.37 Trigeminal neuralgia | 2 0.02 94.39 Trigger finger | 1 0.01 94.40 Trismus | 1 0.01 94.41 Troponin increased | 2 0.02 94.43 Truncus arteriosus persistent | 2 0.02 94.45 Tuberculin test positive | 1 0.01 94.46 Tuberculosis | 3 0.03 94.49 Tumour flare | 1 0.01 94.50 Tumour haemorrhage | 1 0.01 94.51 Tumour lysis syndrome | 3 0.03 94.54 Tumour necrosis | 1 0.01 94.55 Type 2 diabetes mellitus | 4 0.04 94.59 Type IV hypersensitivity reaction | 1 0.01 94.60 Ulcer | 10 0.10 94.70 Ulcer haemorrhage | 2 0.02 94.72 Ulna fracture | 1 0.01 94.73 Umbilical cord abnormality | 2 0.02 94.75 Umbilical cord around neck | 2 0.02 94.77 Umbilical cord short | 1 0.01 94.78 Umbilical cord vascular disorder | 2 0.02 94.80 Umbilical hernia | 1 0.01 94.81 Underdose | 2 0.02 94.83 Unevaluable event | 2 0.02 94.85 Unintended pregnancy | 1 0.01 94.86 Univentricular heart | 1 0.01 94.87 Unresponsive to stimuli | 3 0.03 94.90 Upper gastrointestinal haemorrhage | 1 0.01 94.91 Upper limb fracture | 3 0.03 94.94 Upper respiratory tract infection | 8 0.08 95.02 Upper respiratory tract inflammation | 1 0.01 95.03 Upper-airway cough syndrome | 2 0.02 95.05 Ureteric cancer | 1 0.01 95.06 Urinary fistula | 1 0.01 95.07 Urinary incontinence | 11 0.11 95.18 Urinary retention | 4 0.04 95.22 Urinary tract disorder | 2 0.02 95.24 Urinary tract infection | 27 0.27 95.51 Urinary tract infection bacterial | 1 0.01 95.52 Urinary tract inflammation | 1 0.01 95.53 Urinary tract obstruction | 1 0.01 95.54 Urine abnormality | 3 0.03 95.57 Urine bilirubin increased | 1 0.01 95.58 Urine flow decreased | 1 0.01 95.59 Urine odour abnormal | 1 0.01 95.60 Urine output decreased | 2 0.02 95.62 Urosepsis | 7 0.07 95.69 Urostomy | 1 0.01 95.70 Urticaria | 13 0.13 95.83 Uterine cancer | 2 0.02 95.85 Uterine cyst | 1 0.01 95.86 Uterine enlargement | 1 0.01 95.87 Uterine leiomyoma | 4 0.04 95.91 Uterine mass | 1 0.01 95.92 Uterine perforation | 8 0.08 96.00 Uterine prolapse | 2 0.02 96.02 Uveitis | 2 0.02 96.04 VACTERL syndrome | 1 0.01 96.05 VIIIth nerve lesion | 1 0.01 96.06 VIIth nerve paralysis | 5 0.05 96.11 Vaccination failure | 1 0.01 96.12 Vaginal discharge | 1 0.01 96.13 Vaginal haemorrhage | 7 0.07 96.20 Vaginal infection | 1 0.01 96.21 Vaginal perforation | 1 0.01 96.22 Varicophlebitis | 1 0.01 96.23 Varicose vein | 1 0.01 96.24 Vascular calcification | 1 0.01 96.25 Vascular graft | 1 0.01 96.26 Vascular injury | 1 0.01 96.27 Vascular insufficiency | 1 0.01 96.28 Vascular malformation | 1 0.01 96.29 Vascular occlusion | 1 0.01 96.30 Vasculitis | 2 0.02 96.32 Vasoconstriction | 2 0.02 96.34 Vasodilatation | 1 0.01 96.35 Vein discolouration | 1 0.01 96.36 Vein disorder | 1 0.01 96.37 Velopharyngeal incompetence | 2 0.02 96.39 Venomous bite | 1 0.01 96.40 Venous stenosis | 1 0.01 96.41 Ventricular arrhythmia | 1 0.01 96.42 Ventricular extrasystoles | 1 0.01 96.43 Ventricular hypoplasia | 1 0.01 96.44 Ventricular septal defect | 22 0.22 96.66 Ventricular tachycardia | 4 0.04 96.70 Vertebral artery thrombosis | 1 0.01 96.71 Vertebral foraminal stenosis | 3 0.03 96.74 Vertical talus | 1 0.01 96.75 Vertigo | 7 0.07 96.82 Vertigo positional | 1 0.01 96.83 Victim of abuse | 1 0.01 96.84 Viral infection | 4 0.04 96.88 Viral upper respiratory tract infection | 1 0.01 96.89 Vision blurred | 22 0.22 97.11 Visual acuity reduced | 9 0.09 97.20 Visual field defect | 2 0.02 97.22 Visual impairment | 24 0.24 97.46 Vitamin B12 decreased | 1 0.01 97.47 Vitamin B12 deficiency | 3 0.03 97.50 Vitamin D abnormal | 1 0.01 97.51 Vitamin D decreased | 2 0.02 97.53 Vitamin D deficiency | 4 0.04 97.57 Vitiligo | 2 0.02 97.59 Vitreous floaters | 1 0.01 97.60 Vocal cord disorder | 4 0.04 97.64 Vocal cord paralysis | 1 0.01 97.65 Vomiting | 64 0.64 98.29 Vomiting in pregnancy | 1 0.01 98.30 Vomiting projectile | 1 0.01 98.31 Walking aid user | 1 0.01 98.32 Weight abnormal | 1 0.01 98.33 Weight decreased | 39 0.39 98.72 Weight fluctuation | 1 0.01 98.73 Weight gain poor | 2 0.02 98.75 Weight increased | 36 0.36 99.11 Weight loss poor | 2 0.02 99.13 Wheelchair user | 1 0.01 99.14 Wheezing | 8 0.08 99.22 White blood cell count decreased | 14 0.14 99.36 White blood cell count increased | 11 0.11 99.47 White blood cell disorder | 1 0.01 99.48 White matter lesion | 1 0.01 99.49 Williams syndrome | 1 0.01 99.50 Withdrawal syndrome | 7 0.07 99.57 Wolff-Parkinson-White syndrome congen.. | 1 0.01 99.58 Wound | 7 0.07 99.65 Wound complication | 1 0.01 99.66 Wound dehiscence | 1 0.01 99.67 Wound haemorrhage | 3 0.03 99.70 Wound infection | 5 0.05 99.75 Wrist fracture | 4 0.04 99.79 Wrong patient received medication | 4 0.04 99.83 Wrong technique in drug usage process | 16 0.16 99.99 Yawning | 1 0.01 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 6 Apr 2017